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ABSTRACT 
The purpose of this study was to i) identify usefiil chnical indicators of nutritional 
status readily available to Nutritionists at St Vincent's Hospital and ii) provide 
preliminary data on the effectiveness of their service to head and neck cancer patients. 
Head and neck cancer patients have been identified as a high risk group for 
mahiutrition. The specific clinical indicators of weight, body mass index (BMI), 
triceps skinfold (TSF), mid arm muscle circumference (MAMC), serum albumin, 
haemoglobin and total lyn^hocyte count (TLC) were evaluated in this population. 
Each patient was initially assessed on referral to the Clinical Nutritionist. The patient 
was then assessed weekly until discharge. The initial assessments were then con^ared 
to the final week's assessment. Nutrient intakes were estimated using a diet history 
prior to admission, during admission and one week post discharge. 
Of the 21 patients who participated in the study, 16 had tumours affecting the upper 
gastro intestinal tract (group one) and 5 had brain tumours (group two). Length of 
hospital admission or outpatient treatment (radiotherapy) ranged fiom three to eight 
weeks. The mean changes in anthropometric and biochemical indicators were not 
statistically significant. The number of patients classified as having abnormal or 
borderline values for: BMI (9) and TSF (11) remained unchanged; MAMC (6 to 7), 
haemoglobin* (9 to 11) and TLC* (7 to 8) increased and albumin* decreased (14 to 
13). 
Mean energy and protein intake increased significantly during treatment when 
compared to intake prior to nutrition intervention (369.31 kcalp <0.01 and 19.5g/day 
p <0.025 respectively). Mean estimated energy requirements were not statisticaEy 
different to intake during treatment. In contrast, mean protein intake was significantly 
higher than estimated requirements (p <0.01). One week after discharge, there was an 
insignificant decrease in mean energy and protein intake (119 kcal and 4.92g/day). 
Overall, dietary intake improved for most patients, but signij&cant changes in the 
clinical indicators selected by the Nutrition Services department did not occur. 
Multiple variables afifect the biochemical indicators assessed in these patients, therefore 
their usefiihiess as outcome measures is questionable. Furthermore, for significant 
improvements in the anthropometric indicators to occur, measurements may need to be 
continued for longer periods of time, i.e. post discharge. 
* n=14 
CHAPTER 1: INTRODUCTION 
Outcome measures have begun to emerge in the NSW Health Care System Stricter 
hospital budgets have increased the need for health professionals to demonstrate the 
effectiveness of the services they provide. In the past, supplying hospital administrators 
with data on the efficiency of their department (such as occasions of service) was 
satisfactory to justify staffing levels. The situation has changed, data on the health 
outcomes resulting from an intervention or treatment are now being sought (Leeder, 
1994). 
At the professional level, a coni^rehensive framework to evaluate health outcomes have 
not been developed for Nutrition and Dietetics departments. The Nutrition Services 
Department of St Vincent's Hospital Sydney is preparing itself for the inevitable shift to a 
health outcomes approach to accountabihty, by attempting to characterise usefiil 
performance indicators. 
The purpose of this study was to identify usefiil clinical indicators of nutritional status 
readily available to Nutritionists at St Vincent's Hospital Sydney and provide preliminary 
data on the effectiveness of their service. Head and neck cancer patients presenting for 
active medical and nutrition intervention at St Vincent's Hospital, Sydney were chosen as 
the study population. Head and neck cancer patients were identified by the Nutrition 
Services Department as an inq)ortant area for investigation. 
The objectives of nutritional care for patients with head and neck cancer include: 
ensuring adequate nutrient intake to prevent ftirther weight loss; normahsing biochemical 
abnormahties or preventing fiuther deterioration; assisting in the management of 
symptoms due to the disease or treatment; and supporting quahty of life. 
AIMS 
The specific aims of the research were to: 
a) detemiine whether the readily accessible clinical indicators of nutritional status at St 
Vincent's Hospital are adequate for evaluating the outcome of nutrition intervention in 
head md neck cancer patients. 
b) provide prehminary data on the effectiveness of St Vincent's Hospital's nutrition 
service to the study group. 
OBJECTIVES 
The main objectives of this study were therefore to test the hypothesis that: 
nutrient intake irr^roves or remains adequate after receiving nutrition 
intervention/counselling jfrom the Clinical Nutritionist during a course of active medical 
intervention such as surgery, radiotherapy and chemotherapy, hi addition, this nutrient 
intake would be maintained at one week post discharge from treatment. 
improvements in nutrient intake contribute to positive changes in the respective 
patient's clinical indicators of nutritional status. 
A Secondary objective was: 
To describe the nutritional status of the above population on referral to the Clinical 
Nutritionist and describe the changes in nutritional status during the course of active 
therapy, utihsing the specific clinical indicators of weight, mid upper arm circumference 
(MUAC), mid arm muscle circumference (MAMC), triceps skinfold thickness (TSF), 
serum albumin (Alb), haemoglobin (Hb), and total lymphocyte count (TLC). 
This study was essentially a Pilot Study because of the short period of time 
available for data collection (i.e. two months). It is hoped that data collected may 
be used as a starting point for future research by the Nutrition Services 
Department at St Vincent's Hospital, Sydney. 
Definitions 
The context and meaning in which the following terms are used in this project report are 
described below. 
Active therapy: Any medical intervention including radiotherapy, chemotherapy and 
surgery or a combination of these procedures performed for either curative or palhative 
care. 
Adequate Nutrition: Nutrient intake that meets the patient's estnnated energy, protein 
and micronutrient requirements. Energy requirements were estimated by the Chnical 
Nutritionist using the Schofield equation. Since cancer patients are often in negative 
nitrogen balance, high protein intakes are recommended. Protein intake was estimated 
using 1.2-1.5g protein/kg ideal body weight (Bistrian, 1986). Micronutrient requirements 
were estimated usiag the Recommended Daily Intakes (RDIs) for Austrahans (National 
Health and Medical Research Council, 1991). 
Clinical Indicators: A chnical uidicator is a quantitative measure that can be used as a 
guide to monitor and evaluate the quahty of patient care. The quaUty of patient care is 
determined by several factors including accessibihty, timehness, effectiveness, efficacy, 
appropriateness and confidentiaUty (Anderson and Noyce, 1992). The indicators chosen 
m this study were designed to evaluate the effectiveness component of the quahty of 
patient care. Chnical ittdicators that measure nutritional status were utihsed in this study. 
Curative: "Curative treatment of cancer may be aggressive or radical and is aimed 
primarily at elinmating the disease or curing the patient. Prolongation of life and survival 
are the aims . . (Cochrane and Viney, 1994:88). 
Head and Neck Cancer Patient: a patient with a malignaat tumour in any part of the 
head or neck. For example, a tumour of the tongue, nasopharynx etc (i.e.upper 
gastrointestinal tumours) or brain tumours. 
Nutrition Intervention/Counselling: This refers to the service provided by the Chnical 
Nutritionist and includes: 
• Nutritional Assessment of Patients 
• Enteral feeding regimes when indicated. 
• Counselling patients on the importance of nutrition during therapy, strategies to meet 
their nutritional needs and how to overcome feeding difficulties. For example, advising 
on food texture modification, and ideas for high protein high energy meals, snacks and 
drinks. 
• Providing appropriate written information. 
• Provision of food and supplements for iapatients. 
• Monitoring progress of patients and adjusting regime as necessary. 
Nutritional Status: The nutritional health of a person as determined by anthropometric 
measures (including body mass index, triceps skinfold thickness and mid arm muscle 
circumference), biochemical measures (including albumin, haemoglobin and total 
lym^ihocyte count when available) and dietary analysis. Chnical (physical) examination is 
usually an additional measure, however it has not been evaluated in this project. 
Odynophagia: Pain on swallowing. 
Palliative: "The palhative stage of treatment is when cure is not an expected outcome, 
but the aim is to in^rove the quahty of life through symptom control and management" 
(Cochrane and Viney, 1994:88). 
CHAPTER 2: LITERATURE REVIEW 
2.1. Health Outcomes 
The need for accountability in Australia's health care has resulted in the need to develop 
measures of outcomes. Health outcomes refer to the measured or estimated 
consequences of healthcare interventions. Health outcomes emphasise the change in 
health state following these interventions. Such changes may occur in quality of hfe, 
prolongation of life and prevention of ilhiess (Leeder, 1994). Health outcomes may be 
measured as cases prevented, lives saved, 5 year survival rate, functional status and 
quaUty of hfe. Health outcomes cannot be compared to service indicators i.e. they are 
not length of hospital stay, patient throughput, occasions of service, satisfaction with the 
hotel services of a hospital and quahty assurance (Central Coast Area Health Service, 
Division of Community and Public Health, 1995). 
Clinical indicators that measure health outcomes in the chnical setting are still being 
developed. According to Crowley (1992) "clinical indicators defined as 'a measure of the 
clinical management and outcome of patient care' will initially have an acute hospital 
inpatient medical orientation but the program is e?^ected to expand to encompass other 
health professional groups" (Crowley, 1992:1). Although patient care outcomes are 
related to multi-disciplinary care, Crowley (1992) suggests that chnical indicators in 
Dietetics should reflect aspects of patient care that specifically relates to Dietetic 
management. The Austrahan Council on Healthcare Standards (ACHS Care Evaluation 
Program, 1989) has hsted three requirements of any chnical indicator, which are: 
1) the indicator be relevant to clinical practice 
2) the measure be achievable 
3) data be available on the clinical indicator 
Crowley (1992) suggests that process indicators that are known to lead to high quahty 
patient outcomes may be useful in the Dietetic profession. Clinical indicators for 
oncology, cardiovascular and surgical patients were developed by the American Dietetic 
Association hi 1993. Several of these were process indicators (Queen et al, 1993). The 
use of process indicators appears to contrast to the vision of a Chief Executive Officer in 
a Sydney hospital, (Horvath, 1994), who advocates evaluating the effect of an 
intervention on an individual rather than documentation of interventions performed. 
The health outcomes approach shifts the focus from processes to the effects of 
interventions on peoples health (Horvath, 1994). Horvath (1994) states that we should 
not just look at these effects immediately after the intervention but ideally at least six 
months later. The purpose of this research project was to develop ways to evaluate 
nutrition interventions using an outcome focused approach. However, due to time 
constraints it was not possible to measure the long term outcome of nutrition 
intervention in the study group. Instead an evaluation of the short term effectiveness of 
nutrition intervention and the usefiilness of the chosen clinical indicators of nutritional 
status has been undertaken. 
One of few studies that have addressed the area of nutrition outcomes of care (that is; 
short term effectiveness during hospital admission) was conducted by Weddle et al 
(1995). The objectives of their study included the identification of planned Dietetic 
outcomes of care and outcome achievement. One hundred and seventy-two patients 
wdth various conditions from several hospital sites participated in the study. The main 
inclusion criterion was that the patient received at least 75 per cent of nutritional 
requirements from enteral nutrition products. The mean length of inpatient stay was 
24.75 days and the mean number of study days on tube feeding was 14.5 days. The 
chnical indicators used to measure outcomes included energy intake, visceral protein 
stores (serum albumin), and body weight. Criteria for each indicator respectively were 
set at ± 50kcal of recommended energy intake, ± Ig/L serum albxmiin to maintain 
visceral stores or >3g/L to have increased stores, >lkg for an increase in body weight or 
± 1kg to have maintained body weight. Weddle et al's (1995) results showed that for 
each planned outcome the Dietitian's recommendations were followed for 50-89 per cent 
of patients. These patients were four times more hkely to achieve their recommended 
energy intake goal and increase or maintain visceral protein stores than the patients 
whose recommendations were not followed (Weddle, 1995). However, improvements in 
the visceral protein stores may not be a direct reflection of Dietitians recommendations 
or impact on care per se. They may be simply the result of inq)roving clinical status due 
to recovery from surgery or infection, for exanq)le. The conclusive effect of nutritional 
care can not be determined from their study. Although, the authors feel it may be 
acceptable to make such inferences where specific nutrition outcomes are difficult to 
separate from medical outcomes. Overall, Weddle et al, (1995) concluded that their 
study presented a process that Dietitians can use to identify and measure their own 
planned outcomes of Dietetic related care and demonstrate positive contributions within 
an inter-disciphnary treatment process. 
In recent years in the United States demonstration of the effectiveness of nutrition 
services has been demanded in order to preserve fimding levels for Nutrition and 
Dietetics Departments (Splett, 1991). Such demands have increased the need for 
nutrition outcome studies hke that of Weddle et al (1995). Similarly, Australia is 
proceeding in this direction. Previously simply providing data on efficiency, eg. 
occasions of service, was sufficient to gain fimding. In NSW, AustraUa, Dietitians keep 
statistics on the number of patients they see, the amount of time they spend with them 
and the type of nutrition intervention provided (efficiency data). Capra (1995) feels that 
AustraUan Dietitians have often confiised effectiveness with efficiency and focused on 
process rather than quahty outcomes for chents. This view suggests the need for 
Dietitians to look more at what difference they make to the overall well being of chents 
and develop usefiil ways to measure and record this. 
Controlled clinical trials are expensive, time consuming, and seldom feasible in routine 
clinical practice settings. Studies with less rigorous research design may add to our 
knowledge base, but provide less support for vaUd causal relationships between specific 
nutrition intervention and the health outcome. That is, it is difficult to differentiate 
between the effects of medical and nutrition intervention, without the use of control 
groups. Therefore, such studies offer a weaker basis to justify payment of nutritional 
care (Splett, 1991). Ethical considerations and time hmitations prevented the use of 
control groups in this research project. Therefore we are unable to measure the true 
impact of nutrition intervention but we can infer conclusions regarding the results of the 
proceeding research. 
2.2. Nutrition Outcomes in Cancer Patients 
Dietitians need to demonstrate that there is a benefit to nutrition services even if a 
patient's clinical status deteriorates after recommended dietary modifications are made. 
Evaluating changes in physical status may be unsatisfactory when judging a nutrition 
intervention because disease progression or medical treatment may negate any physical 
improvements produced by the diet (Hauchecome et al, 1994). Other techniques to 
measure the outcomes of nutrition services are needed in this situation. 
Hauchecome et al (1994) undertook a study to develop and test an instrument that 
w ôuld measure respondents' perceptions about the effectiveness or value of nutrition 
counselling; assess v^hether dietary changes occurred after counseUing; assess the 
perceived benefits of any such changes; and reveal any unintended effects of counselling. 
The authors defined effectiveness as "chents' abihty to change their diets and enhance 
their physical and psychosocial w^ell-being after counselling" (Hauchecome et al, 
1994:437). The survey instrument was pilot tested with 33 oncology patients and found 
to be a useftil tool for Nutrition and Dietetics. Overall, the pilot study found that 
Dietitians were perceived as knowledgeable, competent, tmstworthy, caring and 
empathetic. The effectiveness of the work done by Dietitians with these attributes was 
not objectively assessed. Hence this finding should be treated with caution. Some 
respondents reported physical improvement or symptom control, but this was not 
necessary for them to rate their contact with a Dietitian as valuable. All respondents 
either changed their diet or found that their diet was aheady suitable (Hauchecome et al, 
1994). The small san^le size and subjective nature of their research design suggest 
ftirther study is required to ftiUy evaluate the effectiveness of Dietetic intervention to 
their study group. 
However, data provided by Hauchecome et al's, (1994) survey may be particularly useful 
when in^rovements in objective criteria (eg haematology results) are not likely to occur. 
Patients with cancer cachexia may be one group in which such a tool can provide 
valuable results. A similar instrument was unable to be used in the present study because 
of the current demand from hospital administrators to provide objective data and due to 
the hmited size of the study. 
The present study Uke that of Hauchecome et al's (1994), aimed to assess whether 
dietary changes occurred after nutrition counselling. However, the data collection 
methods used to determine changes in nutrient intake in the proceeding study compared 
to Hauchecome et al's (1994) study were quite different. That is, Hauchecome et al's 
(1994), took a more subjective approach to evaluation by simply asking the respondent 
to rate from one to five (strongly disagree to strongly agree) whether a) they did not 
change their diet because it was already suitable; b) they changed their diet after speaking 
to the Dietitian. Whereas this study used the diet history method to assess patients' 
changes in nutrient intake after nutrition intervention. 
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2.3. Effect of Cancer on Nutritional status 
2.3.1. Cancer patients in general. 
Cancer is a general term for a malignant tumour that may develop in any part of the 
body. A tumour is an abnormal growth of cells that spreads and grows at the expense of 
healthy tissue (Eschehnan, 1991). There is often a marked dechne in the nutritional 
status of patients with cancer (Torosian and Daly, 1986). Surgery, radiation and 
chemotherapy are the primary means of treatment, all of which can contribute to this 
deterioration in nutritional status (Kokal, 1985). 
Weight loss may occur early in cancer without a patient changing energy intake or 
physical activity. If the disease does not respond to treatment, the continued metabohc 
demands of cancer cells, anorexia and other nutrition related problems lead to extreme 
weight loss, muscle loss, mahiutrition and eventually a confíete collapse of body 
processes. Such an extreme state of mahiutrition and wasting is called cancer cachexia 
(Eschelman, 1991). Cachexia is considered the end stage of the progressive wasting of 
mahgnancy (Ottery, 1995). 
A review of studies on the prevalence of cancer cachexia (world-wide) by Kem and 
Norton (1988) suggests that over 50% of cancer patients have clinically detectable 
cancer cachexia. The nature and extent of metabohc changes in cancer patients is 
variable (Goodwin and Byers, 1993). Cancer cachexia may stem from two different 
aetiology's. Primary cachexia presents as nutritional deterioration where no consistent 
basis can be found, other than anorexia. Secondary cachexia is defined as weight loss 
and muscle wasting based on mechanical factors such as malabsorption or obstruction or 
it may be related to treatment toxicity (Ottery, 1995). 
In the cancer patient undergoing surgery, malabsorption and hypermetabohsm account 
for some wasting, however post-operatively. Grant (1995) states that most mahiutrition 
is a result of inadequate dietary iatake, both quantitative and quaUtative. This poor 
intake may result from anorexia, altered taste, pain and depression (Grant, 1995; Kokal, 
1985; Donaldson, 1977). Inadequate dietary intake is especially seen in patients with 
tumours of the upper gastro-iatestinal tract (Goodwin and Byers, 1993). 
The goal of nutritional care in patients with cancer is to support nutritional status, body 
composition, fimctional status and quahty of hfe. Research into the effect of nutritional 
support in cancer is controversial and depends on the type and stage of the disease. 
Nayel et al (1992) found that nutritional status improved in head and neck cancer 
patients with nutritional supplementation and counselhng. Whereas Kerstetler et al's 
(1992) study showed that the wasting of cancer cachexia was largely unresponsive to 
aggressive nutrition support. Similarly, Ottery (1995) states that atten^ts to reverse 
severe nutritional depletion are generally unsuccessful. 
Few studies of oncology patients have shovm significant muscular repletion after muscle 
wasting has occurred, although further deterioration can be prevented (Ottery, 1994). 
The effects of changes in eating, nutrition interventions at early stages of treatment, or 
low intensity interventions have not been widely reported in the hterature (Wilson et al, 
1991). Despite this, early nutrition intervention to maintaui body composition and 
nutritional status is favourable to attempting repletion of protein stores close to end stage 
disease or late in a course of treatment. 
2.3.2. Head and Neck Cancer Patients 
Goodwin and Byers (1993) review of research on nutrition in head and neck cancer 
patients indicates that approximately one third of patients with advanced cancer of the 
head and neck are severely malnourished and a fiirther one third suffer from mild 
mahiutrition. The most common cause of mahiutrition in head and neck cancer patients 
is poor nutrient intake, resulting from dysphagia and odynophagia caused by the tumour 
itself (Goodwin and Byers, 1993; Donaldson, 1977). 
Secondary influences on malnutrition in this group include, anorexia, chronic alcohol 
abuse, advanced age (Brookes, 1985) access to food, pain control, nursing care and 
other socioeconomic factors that may create a predisposition to inadequate dietary intake 
(Wüson, 1991). 
Patients with brain tumours may not exhibit the same syn^toms and incidence of 
malnutrition as other patients with cancers of the head and neck. An extensive literature 
search failed to identify studies on the relationship between brain tumours and nutritional 
status. Gadisseux et al, (1984) suggests that there is no reason to beheve that brain 
tumours differ from other mahgnancies in their relation to host metabolism. However, 
patients with brain tumours do not suffer the gastrointestinal obstructions experienced by 
some head and neck cancer patients, which can severely limit food intake. 
Severe mahiutrition is clearly associated with poor response to cancer therapy, immune 
suppression, poor wound heahng and decreased survival (Goodwin and Byers, 1993). 
The high prevalence of mahiutrition in head and neck cancer patients with tumours in the 
upper gastrointestinal tract, at the time of diagnosis presents major challenges in all 
phases of treatment (Bassett and Dobie, 1983). Primary treatment by surgery, 
radiotherapy or chemotherapy may fiirther compromise any pre existing nutritional 
deficiency. When a malignancy in the head and neck region becomes evident, an 
assessment of nutritional status is advantageous so that existing deficits may be 
addressed, preferably prior to the commencement of therapy (Basset and Dobie, 1983). 
The maintenance of nutritional status in all cancer patients is a critical part of their 
overall care. The failure to address nutrition is associated with longer hospital stays, 
increased risk of corr^)lications and death and higher health care costs (Ottery, 1995). 
2.4 Indicators of nutritional status in head and neck cancer patients 
Debate continues among clinicians about the best method for assessing nutritional status. 
To date, no single parameter has been found that can be used as a con^letely rehable 
index of nutritional status (Brookes, 1985). However studies have shown that using a 
range of measurements will increase the accuracy of nutritional assessments. 
A nutritional assessment involves evaluating the nutritional status of individuals through 
measurements of nutrient intake and several nutrition related health indicators (Lee and 
Nieman, 1993). Various techniques are used to obtain information about a person's 
nutritional status. The most widely used technique involves direct and indirect measures 
of body protein, which is stored as somatic (muscle) and visceral protein. 
Anthropometric indicators and laboratory tests are used to measure these parameters 
(Brookes, 1985). The anthropometric, biochemical and dietary measurements utihsed in 
studies with cancer patients vary widely. These techniques will be discussed below. 
The most simple and common indicator used to monitor nutritional status is weight. 
This method was used by Donaldson (1977), who found that the average weight loss for 
122 head and neck cancer patients undergoing radiotherapy was 3.7kg over a period of 
six to eight weeks. These patients did not receive specific dietary treatment. Chambers 
(1993) also used body weight to investigate changes in nutritional status of patients 
undergoing radiotherapy (n=39 three were head and neck cancer patients). An average 
weight loss of 2.0kg was reported (Chambers, 1993). Nutrition counselling was 
available to patients in Chambers' (1993) study, however the direct impact of this on 
weight was not measured. 
Other studies have used a combination of chnical indicators. A study by Brookes (1985) 
assessed the possible prognostic value of nutritional status in 114 patients with untreated 
primary squamous cell carcinoma (SCC) of the head and neck. Nutritional status was 
evaluated by anthropometry (MAMC, TSF, weight change and weight change relative to 
the ideal weight for height), creatinine height index estunation, serum albumin and 
transferrin assays and nitrogen balance studies. The parameters of relative weight 
change and arm muscle circumference were averaged to obtain a general nutritional 
status (GNS) score. 
Brookes' (1985) study showed that the anthropometric indices gave reproducible data 
and that the GNS score gave a significant positive correlation with serum albumbi. A 
low serum albumin was invariably associated with a low GNS score, but normal albumin 
values were found in more than 50% of undernourished patients. The normal values 
found in such cases was not fiirther discussed by the researchers. Factors affecting 
albumin levels such as dehyration (resulting in elevated values) were not considered in 
Brookes' (1985) study, therefore these results should be interpreted with caution. 
Serum transferrin, creatinine height index and nitrogen balance studies were found to be 
frequently unreliable in Brookes' (1985) study. The incidence of mahiutrition in the 
study group was 15%, with 37% suffering fi-om under-nutrition at presentation. The 
undernourished patients had a highly statistically significant difference in survival at one 
year than the adequately nourished patients. Most (81.4%) of the undernourished 
patients had a tumour arising fiom the upper GI tract (Brookes, 1985). This finding was 
consistent with previous studies and en^hasised the importance of regarding the oral 
cavity, oropharynx, hypopharynx and cervical oesophagus as at risk sites for nutritional 
deficiency irrespective of tumour stage. 
Fifty patients with untreated head and neck cancer were studied by Bassett and Dobie 
(1983) to determine nutritional status independent of treatment effects. Anthropometry, 
biochemistry and assessment of oral food intake were used to evaluate nutritional status. 
The specific clinical indicators used included; weight, per cent of ideal body weight, TSF, 
MAMC; Hb, Alb, transferrin, TLC and creatinine height index. Forty per cent of the 
population was characterised as having good nutrition, 20% fair and 40% poor nutrition. 
The most sensitive laboratory indicators of mahiutrition were shown to be serum 
transferrin and creatinine height index (Bassett and Dobie,1983). Serum transferrin is 
thought to be a more sensitive indicator of visceral protein than serum albumin due to its 
shorter half life. However, Brookes' (1985) study found that transferrin was generally an 
unrehable indicator in their study group (i.e. cancer patients) due to the impact of other 
variables such as dehydration and inflanmiation. The most sensitive anthropometric 
measurement found by Bassett and Dobie (1983) was the mid upper arm muscle 
circumference. The best predictor of in^aired nutritional status among other clinical 
variables studied was the patient's description of his recent diet, a general diet (i.e. oral 
diet with no texture modifications) predicted a good score, whereas diets restricted to 
soft or hquid foods predicted a fair or poor score. 
In another study, the change in nutritional status of 71 oncology patients during a course 
of head and neck radiotherapy at Royal Prince Alfred Hospital was described (Boffo and 
Faulkner-Hogg, 1995). Their study was an extension of a pilot study that examined the 
changes m nutritional status of 23 patients with tumours in the head, neck and pelvic 
region of the gastro-intestinal tract over six weeks of radiotherapy. (Carey, 1992). 
Routine Dietetic counselling was available to aU patients during both studies. Nutritional 
assessment included anthropometry (BMI, TSF, subscapular skinfold, MUAC and 
MAMC), biochemistry (albumin and transferrin) dietary intake (24 hour recall) and the 
presence of side effects (Boffo and Faulkner-Hogg, 1995 and Carey, 1992). 
Boffo and Faulkner-Hogg's (1995) study found that 40 per cent of patients were 
considered malnourished at the commencement of therapy, while a fiirther 8 per cent 
were considered malnourished at the end of therapy (i.e. a total of 48 per cent). Seventy 
per cent of patients reported that side effects were affecting their abihty to eat and drink. 
The main recommendation made by the authors was that screening of patients for 
mahiutrition appears to be more appropriate at the time of diagnosis rather than during 
the course of treatment. The ideal measure for nutritional status in clinical practice was 
not identified by this study, nor has it been estabhshed elsewhere. Boffo and Faulkner-
Hogg (1995) suggest that using more than one measure is more accurate in identifying 
patients at risk of becoming malnourished than a single indicator because some indicators 
are less rehable than others (depending on the patients medical condition). 
An earher study of cancer patients prior to surgery, used the Prognostic Nutritional 
Index (PNI) to identify operative risk and possible candidates for preoperative nutritional 
support (TPN) (Smale et al, 1981). The PNI included measures of fat stores (TSF), 
visceral proteins (albumin and serum transferrin) and immunocompetence (measured by 
delayed hypo sensitivity reactivity to three common antigens). The investigators suggest 
that their study provided strong evidence that the PNI can identify a subset of major 
surgery cancer patients who are at high risk for nutritionally based operative morbidity 
and mortahty and in whom pre-operative nutritional support (TPN) can significantly 
reduce such outcomes (Smale et al, 1981). However, few other studies with cancer 
patients that used several outcome measurements, including overall survival have 
reported a significant benefit to nutritional support (Ottery, 1995). Flaws in the design 
of such studies have been blamed for these results. That is, the most malnourished 
patients were given the most aggressive intervention possible. It is now well estabhshed 
that reversal of deterioration during end stage disease is an unlikely outcome. 
Furthermore, nutritional support does not solely mean TPN, it may incorporate it as a 
tool, but it generally encompasses aU forms of nutrition intervention including, oral and 
enteral feeding. 
Grant (1995) fiirther highlights the multiple design errors in previous chnical trials that 
failed to demonstrate any advantage of nutritional support in the cancer patient. These 
errors include; poor patient selection vsdth minimal standardisation of cancer type or 
stage; limited control of other risk factors, such as age and medical ilhiesses; use of 
poorly designed study endpoints; poor documentation of the degree of malnutrition 
present; variable time frame when nutritional support was given and variable adequacy of 
that nutritional support; frequent grouping of patients undergoing surgical and non 
surgical therapy; and inadequate numbers of study patients (Grant, 1995). The limited 
scope of such research must be considered when interpreting the findings of these clinical 
trials. 
A study by Grey and Meguid (1990) on the effect of nutritional therapy (TPN) in 22 
patients with cancer (ten patients had head and neck tumours) and hypoalbuminaemia 
found that low serum albumin does not reflect nutritional status. Two thirds of the 
patients were considered malnourished as defined by anthropometric measurements 
before receiving nutritional therapy. All patients had initial serum albumin values of less 
than 35g/L. Albumin levels failed to increase after 21 days of TPN despite a significant 
increase in body weight. The authors concluded that hypoalbuminaemia in patients with 
cancer is a consequence of disease. Klein (1990) supports this view, and states that 
although inadequate nutrition may contribute to hypoalbuminemia in hospital patients, 
the metaboHc response to stress is a more important factor. Hence this suggests that 
"serum albumin concentration correlates with disease severity in hospitahsed patients but 
is inappropriate as a measure of nutritional status" (Klein, 1990:1846). Similarly, 
albumin has been reported to be an inadequate indicator of nutritional status in several 
other studies (O'Keefe and Dicker, 1988), therefore its usefiihiess as a clinical indicator is 
debatable. 
The above research provides limited support for the use of albumin in evaluating 
nutritional status. However the limitations of such studies must also be considered, such 
as the sole rehance on TPN for nutritional support rather than enteral or oral nutrition 
intervention. When used in combination with other variables (eg TLC) the use of 
albumin in nutrition assessment has been supported by several authors including 
Beaudette (1994), and Goodwin and Byers (1993). Although, tests for serum albumin 
are routinely performed on most hospitalised patients making it an easily accessible 
indicator of nutritional status, its use should still be questioned. 
2.5 Effect of Nutrition Counselling 
A randomised study of the effect of regular and long term nutritional counselling on 
dietary intake (3 day diet diary); anthropometric measm-ements (including TSF, weight, 
MUAC and MAMC); response rates and overall survival; and quahty of life (modified 
version of the quahty of hfe index questionnaire) was conducted with 105 patients 
undergoing curative chemotherapy for breast, ovary or lung cancer (Ovesen et al, 1993). 
Fifty seven patients were randomised to receive nutrition counselling and 48 received no 
nutrition coimselling. The intervention group were counselled to achieve a daily energy 
and protein intake according to recommended dietary allowances by a Dietitian twice 
monthly during five months of chemotherapy. This group increased their daily energy 
intake by approximately 1 MJ and protein by lOg over the study period. There was no 
change in the control group. Tricep sldnfold measurements increased significantly after 
five months however the increase in body weight was insignificant and there was no 
significant increase in lean body mass. Despite the increased food intake, improvements 
in nutritional status, survival duration, and quahty of life could not be shown in Ovesen 
et al's, (1993) study. 
In comparison, Nayel et al's (1992) study of head and neck cancer patients showed that 
significant improvements in nutritional status occurred when patients increased their 
nutrient intake. Nayel et al (1992) examined the impact of nutritional support and 
counselling on 23 patients with head and neck tumours undergoing treatment with 
irradiation. These patients were randomised to receive either radiotherapy alone (12 
patients) or radiotherapy plus oral supplementation with a high protein nutritional 
powder. In addition, these patients were encouraged to choose soft non irritant high 
energy foods. Nutritional status was assessed subjectively and objectively for all patients 
before and at weekly intervals during the course of irradiation. All patients who received 
oral nutritional supplementation experienced significant increases in body weight, mid 
arm muscle circumference and triceps skinfold measurements. However 58 per cent of 
patients who were treated with radiotherapy without nutritional support experienced 
weight loss and 33 per cent experienced a decrease in both mid arm muscle 
circumference and triceps skinfold thickness. The authors also noted that five of the 
twelve patients who did not receive nutritional support had their irradiation suspended 
because of poor performance status, whereas aU patients who received nutritional 
support during radiotherapy had their course of irradiation without interruption. 
In summary, the preceding review of Hterature highhghted that the nutritional status of 
head and neck cancer patients is often compromised. Therefore nutritional assessment 
and support should be an integral part of therapy for these patients. To date, clinical 
indicators that measure the outcome of nutritional support have not been developed on a 
professional level. However several indicators have been frequently used in research to 
describe the nutritional status of cancer patients. A combination of biochemical (eg 
albumin, total lyn^hocyte count and haemoglobin) and anthropometric measurements 
(eg body weight, triceps skinfold thickness and mid arm muscle circumference) were 
used in these studies as single measures were considered less accurate. 
CHAPTER 3: METHODOLOGY 
3.1 Dietary intake 
Few atten^ts have been made to accurately describe the energy and protein intakes of 
oncology patients. Hohoyde and Reichard (1986) beUeve that this is due to the 
limitations of retrospective dietary analysis and patient recall. There are several methods 
that can be used to collect dietary intake data, all of which have numerous benefits and 
limitations. 
A diet history is used to assess an individual's usual dietary intake over an extended 
period of time such as the past month (Lee and Nieman, 1993). Structurally the diet 
history takes the form of a description of meals typically consumed throughout the day 
with a food frequency cross check. 
The reproducabiUty of a diet history questionnaire in a case control study of breast 
cancer patients found that it was reasonably reproducible in three of the four groups of 
subjects studied (Hankin et al, 1983). Other studies that have used the diet history 
method include the Diabetes Complications and Control Trial (DCCT). The modified 
Burke (1947) diet history method used in the DCCT was found to have good 
reproducibihty (Schmidt et al, 1994). The rehabihty of this method has been found by 
most investigators to be very good (Block, 1982 and Block, 1989). However the 
vahdity (in relation to precisely reflecting the truth) of the diet history method cannot be 
known. The vahdity depends on the participant's ability to give correct information on 
frequency and an abihty to estimate portion sizes correctly (Bingham et al, 1988; Webb 
and Yuhas, 1988 and BoUand et al, 1990). 
Other advantages of the diet history method include that estimates of protein intake have 
been shown to correlate well with measures of nitrogen excretion (Jain, 1989) and data 
on all nutrients can be obtained. Limitations of this method include the lengthy period of 
time required to conduct the interview and the dependence on the respondent's ability to 
recall their usual intake (Lee and Nieman, 1993; Bingham et al, 1988). Furthermore, 
recent studies have shown that intakes assessed by the diet history appear to be greater 
than those obtained from records, possibly due to the tendency of subjects to 
overestimate how often they consume foods (Bingham, 1987). 
Cypel and Slesittski (1994) stress that participants in dietary surveys may under-report 
high intakes or over-report small intakes of foods that they perceive as having greater or 
lesser degrees of healthftihiess. In addition, they may forget to include aU foods eaten, 
especially added foods such as condiments and sauces. 
In summary, the modified Burke's (1947) diet history method (i.e. without the 3 day food 
record) was chosen in this study for several reasons including: 
• it is similar to the current method Dietitians use in clinical practice to assess dietary 
intake. 
• it appears adequate to determine the typical diet and provide a representative picture 
of the individuals average intake (Block, 1982). According to Smith (1991) most people 
are able to report what they typically eat, even if they cannot report exactly what they ate 
during some specific period of time. 
• other dietary intake methods were less appropriate for a small study group. For 
example, the 24 hour recall method is less accurate for assessing the usual intake of an 
individual, despite the value shown in assessing the average intake of a large group 
(Block, 1982). 
The follow-up diet history taken after patient discharge was mostly conducted on the 
telephone. Telephone follow up dietary surveys have been shovm to be superior in 
response rate to mail follow up and good correlations have been found between the same 
instrument administered over the telephone and face to face (Fox et al, 1992). 
3.2 Anthropometric Indicators 
• Body weight can be evaluated using the Body Mass hidex (BMI). The Body Mass 
Index is defined as weight/height^ (Thomas, 1994). This method is convenient and quick 
to calculate, however it does have its limitations. The most significant one is that it does 
not provide information on body con^osition. However, body weight can give an 
overall indication of body fat and muscle protein stores (Grant et al, 1981) and may be 
usefiil when assessed together with other measures of body composition. 
• Self reported height was used in this study rather than measured height. Several 
studies have examined the vahdity of self reported height with variable results. A study 
by Zhang, Feldblum and Fortney (1993) of 353 women aged 40 to 54 compared 
measured to reported height. They found that self reported height was extremely 
accurate in this group (r = 0.96) and concluded that in similar groups self reports are 
quite vahd and no measurement is necessary. A similar study by Stewart et al (1987) of 
1598 people (65% males) aged 35 to 65 found that reported height was no more than 
3.5cm fi-om their measured height indicating a high degree of accuracy. Stewart's (1982) 
study provides fiirther support for the use of self reported height, the results indicating 
that this measure was vahd and rehable. However Rowland (1990) found that despite 
height being reported with smaU errors in most of his 11 284 person sample, self reports 
were found to be unrehable in certain population sub groups. Errors in self reporting 
height were related to a persons age, with rehabihty decreasing after age 45. Small sex 
differences in misreporting were found by Paha et al, (1982). Height was overstated by 
1.3% by men and 0.6% by women (Paha et al, 1982). Overall, the hterature appears to 
support the use of self reported height, finding oiily small variations between measured 
and reported height. 
• A weight history is useftil to detect current and potential nutritional compromise. A 
weight loss of greater than 10% of previous body weight in less than twelve months is 
considered a risk factor for malnutrition and a weight loss exceeding 20% may be 
associated with an increase in mortaUty and morbidity (Goodwin and Byers, 1993). It is 
inq)ortant to note however that patients often underestimate their usual weight to 
minimise weight loss (Morgan et al, 1980). 
Body composition measurements 
The mid-upper arm circumference (MUAC), triceps skinfold (TSF) and mid arm muscle 
circumference (MAMC) have been used in numerous studies that have assessed 
nutritional status in hospitahsed (Bishop et al, 1981) and non hospitaUsed patients. 
These parameters can be measured with a minimum of equipment, effort and time. 
However, research by Collins et al, (1979) suggests that monitoring MUAC and MAMC 
in individual patients may not be rehable in assessing changes in body nitrogen over short 
periods of time because protein stores can not be rapidly replenished. 
• A skinfold is a double fold of skin and con^ressed subcutaneous adipose tissue. 
Skinfold measurements are the sirq)lest technique available to quantitate adipose tissue 
stores. The equipment needed is inexpensive and requires httle space. However, several 
limitations of skinfold thickness measurements have been identified by Jensen (1992). 
These include: 
overestimation of body fat in oedematous patients. 
skinfold data are most commonly vahdated with measurements from healthy young 
men and women which may differ from the population being examined. This should be 
considered when interpreting results. 
The triceps skinfold (TSF), is the most commonly used single site for assessing body 
composition. The triceps skinfold site is located midway between the lateral projection 
of the acromion process of the scapula and the olecranon process of the uka. The 
measurement is taken when standhig behind the subject while their arm is hanging loosely 
at their side (Thomas, 1994 and Lee and Nieman, 1993). 
The limitations of using a single site as an index of body composition are numerous. 
Multiple anthropometric measures are required to achieve reasonably accurate body 
composition estimates because of the variations in subcutaneous adipose tissue 
distribution. Lee and Nieman, (1993) state that when single site measurements must be 
used, they should be compared with reference data from large population studies and 
interpreted with caution. 
• The MUAC is measured with a tape measure at the level of the triceps skinfold with 
the subject standing. As an indicator of muscle and subcutaneous adipose tissue, it is an 
accepted measure of nutritional status (Chumlea et al, 1988). 
• The TSF and MUAC can be used to calculate the mid arm muscle circumference 
(MAMC). This is a measurement of lean arm tissue which can be compared with 
previous values or standard norms. Hence, providing a usefiil estimate of muscle protein 
stores in non oedematous patients. Some studies question the correlation between 
MAMC and body muscle mass. Collins et al, (1979) and Jeejeebhoy et al, (1982) studies 
found that total body nitrogen did not correlate with MAMC. Furthermore, due to the 
inherent imprecision of the TSF and MUAC measurements the reproducibility and 
validity of MAMC have been questioned. The variation among three different observers 
for TSF and MUAC measurements was found by Hall et al, (1980) to be 22.6 per cent 
and 4.7 per cent respectively. Hall et al, (1980) therefore suggested that to be able to 
conJBrm a true change in MAMC calculated from MUAC and the TSF, the change needs 
to be at least 2.68cnL 
3.3 Biochemical Indicators 
• The visceral protein corq)artment is assessed by determining the plasma levels of 
transport proteins such as albumin, transferrin and pre albumin. A decrease in serum 
concentration of these proteins is a consequence of decreased liver biosynthesis which is 
due to a limited supply of substrates. This is associated with mahiutrition. 
Albumin has been used to indicate visceral protein depletion in several population 
studies (Grant et al, 1981 and Donaldson and Lenon, 1979). Albumin has a half life of 
18 to 20 days, therefore its usefiilness in detecting acute changes hi nutritional status is 
limited (Lipkin and Bell, 1993). Thus albumin reflects a chronic rather than acute protein 
depletion. Depressed albumin values may occur in a patient for various reasons other 
than mahiutrition, such as fluid retention, liver or renal disease and normal aging. Hence, 
care should be taken when interpreting low values (Zeman, 1991). Although pre-
albumin has been shown to be a more sensitive indicator of protein status than albumin 
because of its two day half life (Grant et al, 1981), this test is not routinely available. 
Hypoalbuminaemia is a consistent finding in cachectic cancer patients which is assumed 
to be the result of decreased hepatic synthesis of albumin. However, recent animal 
studies suggest that depressed serum albumin levels are a result of increased albumin 
degradation (Kem and Norton, 1988). As discussed previously, on its own serum 
albumin does not appear to reflect nutritional status in cancer patients. Cancer cachexia 
is associated with abnormal protein metabohsm, hence oversiir^lified conclusions about 
nutritional status fi-om serum albumin concentrations should not be and will not be made 
in this study. However, when interpreted with other indicators such as TLC it may 
provide more valuable data. 
• Since mahiutrition causes an acquired immune deficiency, markers of immune fimction 
may reflect visceral protein stores in the absence of other immunosuppressive factors 
(Goodwin and Byers, 1993). Changes in immune response can occur early in nutritional 
deficiency, hence immunocompetence can be used as an early fimctional indicator of 
nutritional status and as an index of response to nutritional support (Chandra, 1991 and 
1981). Immunological changes are good indicators of general nutritional deficit but can 
rarely identify specific nutritional deficiency (Young et al, 1990 and Chandra, 1981). 
The half Ufe of different lyn^hocytes is variable. Some white blood cells only hve a few 
days. Their constant resynthesis requires a steady nutrient input, especially fi-om protein, 
vitamin B6 and B12, folate, zinc and Vitamin A (Wardlaw and Insel, 1990). 
Total lymphocyte count (TLC) is the most commonly used measure of cell mediated 
immunity (this can be calculated from the differential and white blood cell count). 
Several studies in cancer populations have used TLC as an indicator of nutritional status 
in combination with other parameters. Research by Bassett and Dobie (1983) which 
examined patterns of nutritional deficiency specifically in head and neck cancer patients 
(Bassit and Dobie, 1983) used TLC as a chnical indicator. Their study found that mean 
TLC feU within the normal range (1856 ± 846/mm^) whereas the results fiom the skin 
tests (cutaneous reactivity) were more likely to be abnormal. This suggests that TLC 
values may not be as sensitive as desired and other indices need to be examined. 
Factors affected TLC other than nutritional status include cancer, stress, steroids and 
Chemotherapeutic agents (Lee and Nieman, 1993). Total lymphocyte count is not an 
absolute indicator of nutritional status but Beaudette (1994) states that it may be a useM 
indicator of mahiutrition, especially if both TLC and serum albumin are low. TLC will 
be calculated for all subjects in this study and its limitations considered in data analysis. 
• Haemoglobin (Hb) tests are used to screen for iron deficiency. Hb consists of a 
protein globin and heme. For the formation of Hb molecule, good protein and iron 
stores are required and deficiencies of both are associated with anaemia (Wahlqvist, 
1988). Iron deficiency may result from in^aired absorption, increased loss, increased 
requirements and inadequate dietary intake (Zeman, 1991). The half hfe of Hb is 120 
days. Hence, although Hb values are usefiil in diagnosing anaemia, they tend not to 
become abnormal until the late stages of iron deficiency and are not good indicators of 
early iron deficiency (Lee and Nieman, 1993). These factors should be considered in 
data interpretation. 
Haemoglobin was one of several indicators of nutritional status used for 50 patients 
newly diagnosed with head and neck tumours in Bassett and Dobie's (1983) study. The 
serum haemoglobin level was used as a measure of visceral proteia. The mean 
haemoglobin value for the group was 13.9 ± 1.9 gm/dl which corresponds to the lower 
limits of normal. Hb was not found in this study to be the most sensitive indicator of 
protein calorie depletion (Bassit and Dobie, 1983). Haemoglobia may be a useful 
indicator of protein or iron deficiency when interpreted along with other clinical 
indicators such as albumin when conducting initial assessments of nutritional status. 
However, haemoglobin's long half hfe make its usefulness in monitoring nutritional status 
in short stay hospitahsed patients questionable. 
In summary, the use of dietary intake data in combination with anthropometric indicators 
(such as body weight, triceps skinfold and mid arm muscle circumference) and 
biochemical indicators (such as albumin, haemoglobin and total lymphocyte count) have 
been considered adequate for evaluating nutritional status (by some researchers). 
However, the limitations of these methods should be considered when interpreting 
results. 
CHAPTER 4: MATERIALS AND METHODS 
The protocol was submitted to and approved by St Vincent's Hospital Research Ethics 
Committee and the University of Wollongong's Human Experimentation Ethics 
Committee (Appendix A). 
4.1. Setting 
The study was conducted with the Nutrition Services Department at St Vincent's 
Hospital Sydney. At the time of the study St Vincent's Hospital was a 420 bed teaching 
hospital, conducted by the Sisters of Charity. Head and Neck Oncology (radiation, 
medical and surgical) were some of the speciahty areas of the hospital. 
4.2. Time Period 
Data collection occurred between August and October 1995. 
4.3. Subjects 
Head and neck cancer patients were selected as the study population for several reasons 
including: 
a) they all required nutrition intervention 
b) the population was easily defined 
c) manageable group size. 
A convenience sangle of inpatients and outpatients with head and neck cancer, receivittg 
active medical and nutrition intervention at St Vincent's Hospital Sydney were recruited 
to take part in this study. A convenience sangle was chosen because of time and 
resource constraints. Hence the sangle size was determined by the number of 
admissions fitting the selection criteria during the study period. A total of 21 patients 
participated in the study. 
All medical consultants and nursing unit managers involved with the care of head and 
neck cancer patients were informed of the study and access to their patients was 
requested. Consent to conduct this research was provided by these health professionals. 
All head and neck cancer patients undergoing active medical treatment (who met the 
inclusion criteria below) were referred to the Clinical Nutritionists during the study 
period. Routine nutrition intervention and counselling were provided to all patients in 
the study. A control group was not included in this study as it was unethical to deny 
usual care to patients. 
The investigator explained the study to each patient after their initial consultation with 
the Nutritionist. Written consent was obtained from those who agreed to participate 
(Appendix B). 
4.4. Inclusion Criteria 
• The patient had a type of head and neck cancer. 
• The patient was undergoing active medical treatment for cancer; i.e radiotherapy, 
surgery or chemotherapy for curative or palHatrve care. 
• The patient was referred to the Clinical Nutritionist. 
• The patient was admitted to St Vincent's Hospital, Sydney or commenced treatment at 
this institution during the study period 
• The patient was Enghsh speaking 
• The patient was able to communicate verbally 
• The patient had consented to participate. 
4.5. Exclusion Criteria 
• Those patients with head and neck cancer receiving active medical intervention for 
tumours in regions other than the head or neck. 
• Any patient that did not fit the iaclusion criteria. 
4.6. Procedure 
The patient was referred to the Chnical Nutritionist. 
4.6.1. Nutrition Intervention. 
As part of the usual consultation with a Clinical Nutritionist the participaat's nutritional 
status was assessed (using the techniques described below) and their nutritional 
requirements estimated. The patient was then provided with appropriate nutrition 
counselling and/or prescribed an enteral feeding regime. The nutrition intervention 
provided was recorded by the investigator. 
4.6.2. Background Data 
The patients medical record was used to obtain background data including: age, sex, 
diagnosis, date of diagnosis, site of cancer and type of treatment. 
4.6.3. Anthropometry 
Body corr^osition was assessed using non iavasive techniques. Each patient was 
interviewed regarding their weight history and reported their height during the first 
assessment. The mid upper arm circumference (MUAC), triceps skinfold thickness 
(TSF) and weight were measured by the investigator at the initial visit and then at weekly 
intervals. The MUAC was measured using a tape measure and the TSF was measured 
using the Holtain skinfold cahper. Mid arm muscle circmnference (MAMC) was then 
calculated using the formula: MAMC = MUAC(cm) - 0.3142TSF(cm) (Thomas, 1994 and 
Lee and Nieman, 1993). Weight was recorded using standard scales and Body Mass Index 
(BMI) estimated using reported height. 
4.6.4. Biochemistry 
Biochemistry results for serum albumin (Alb), haemoglobin (Hb), and total lymphocyte 
count (TLC) were obtained at weekly intervals from medical records, when available. 
4.6.5. Classification of clinical indicators 
The percentile for each TSF, MUAC, MAMC and BMI were estimated using age and 
sex specific reference values developed by Bishop et al (1981). Serum albumin, 
haemoglobin, TLC, TSF, MUAC, MAMC and BMI were then ranked as normal, 
borderline or abnormal as outhned in Table 4.1. Two or more abnormal values or three 
or more borderline measures may indicate the need for increased nutritional therapy. 
4.6.6. Food intake 
A diet history (modified Burke method (Burke, 1947)) was taken for all patients during 
the initial consultation with the clinical nutritionist (or the first interview with the 
investigator). The patient was asked to describe their usual food intake prior to 
commencement of treatment. A second diet history was taken by the investigator during 
the course of treatment for those having an oral diet. For those patients receiving enteral 
feeds their nutrient intake was recorded from the medical notes. A follow-up diet history 
interview was conducted either by telephone or face to face one week after discharge 
from treatment. The same questions and format were used at each interview to ensure 
the data were consistent and reUable. 
Visual aids (such as cups and hand drawn diagrams) were used to help estimate portion 
sizes and a food frequency checkUst was used to pron^t the patient of missing items at 
the end of each interview (Appendix C). In addition, the patient was asked whether they 
modified the texture of their food. Some patients wrote down what they had been 
generally eating prior to the second diet history interview. Further details were ehcited 
from such patients as necessary. 
The food items consumed in an "average day" by each patient (prior to, during and after 
treatment) were analysed using the nutrient analysis software package Diet Version 2.05 
(Xyris Software Austraha, Pty Ltd, 1989). Estimates for total energy, protein, and 
essential nutrient (RDIs) iatake were recorded. 
4.6.7. Symptoms Questionnaire 
The presence of common syniq)toms experienced by head and neck cancer patients 
undergoing active treatment was determined for each patient each time a dietary history 
was taken, that is, prior to, during and after con^letion of treatment (Appendix D). No 
attempt was made to describe the degree of severity of each synq)tom that was present. 
The number and percentage of patients wdth each symptom were calculated at each 
interval and the trends described. 
4.7 Data Analysis 
4.7.1. Statistical Analysis 
The paired t-test was apphed to the nutrient intake data to determine dififerences in 
protein and energy intake prior to treatment, during treatment (i.e.before and after 
nutrition intervention) and at one week post discharge follow-up (A,B,C). In addition, 
the differences between estimated protein and energy requirements during treatment 
were compared to each patient's estimated intake and tested for significance (using the 
paired t test). The means, standard deviations and standard errors were calculated for 
the anthropometric and biochemical on commencing the study and upon discharge. 
Microsoft Excel Version 2 for IBM and manual calculations were used to compute the 
results. 
Note: 
A= initial assessment either prior to or on commencement of therapy 
B= approximately mid way through the course of therapy 
C= one week after discharge from therapy. 
4.7.2. Descriptive Analysis 
Due to the small sample size and minimal changes in the chnical indicators observed, 
the anthropometric and biochemistry results were presented graphically and the trends 
described. 
Table 4.1; Classification criteria for each assessment parameter 
Classification 
Indicator Normal Borderline Abnormal Reference 
BMI^ 20-25 18-19 <18 Grant et al 




10-95 5-9 <5 Smith and 
Mullen(1991); 




11-95 5-10 <5 Smith and 
Mullen(1991); 
Gray and Gray, 
(1979) 
Alb g/L (half life = 
18 -21 days) 
40-52 35-40 <35 Smith and 
Mullen(1991); 
Grant et al 
(1981) 







TLC 109/L® 1.5-3.5 N/A <1.5 Thomas, (1994) 
* The time required for a change in skinfold thickness and muscle circumference to 
occur is highly variable. Standards that specify expected times for change in these 
parameters were not available. 
# Weight may fluctuate daily due to changes in fluid balance, however for a loss in either 
muscle or fat stores to occur a minimum of a week may be required. 
® The life span of lyrqphocytes ranges from three to five days to months and years. 
Despite the long hfe span of some lymphocytes, changes in total lymphocyte count may 
occur within a week. 
CHAPTER 5: RESULTS 
5.1. Patient Profile 
Twenty-one participants completed the study. Two subjects (of the 21) withdrew after 
discharge fi:om treatment, therefore dietary data was not available one week after 
discharge for these patients. For most analyses the participants were divided into two 
main groups. Group one consists of patients with tumours in the head and neck region 
of the gastro-intestinal tract (GIT). Group two consists of patients with tumours of the 
brain. Refer to Appendix E for all raw data. 
Group one. 
Sixteen patients, thirteen males and three females undergoing active medical intervention 
were referred to the Clinical Nutritionist. All patients approached agreed to participate 
in the study (100 per cent response rate). The mean age of the group was 65 (± 9.2; 
range = 49-84). 
Eight (50%) participants underwent both surgery and radiotherapy during the study 
period. Four patients had radiotherapy only and the remaining four patients had surgery 
only. The duration of radiation therapy ranged from 20 - 35 days (mean = 30 ± 8). One 
patient terminated therapy prior to con^letion due to poor tumour response. The most 
common surgical procedures performed included a Pharyngeal laryngectomy and jejunal 
free flap repair (Refer to Appendix F for all procedures performed). The length of 
hospital stay for surgical patients ranged from three to nine weeks (mean = 4.5 weeks; ± 
1.9). 
Most patients (n=15) commenced active medical treatment between one and eight 
weeks from their date of diagnosis. One patient commenced treatment several months 
after diagnosis. 
Group two. 
Five patients (two males and three females) with various types of brain tumours 
participated in the study. A fiirther two were approached but did not participate 
(response rate 71%). The mean age was 42 (± 17.6; range = 29 -75). Two patients 
underwent chemotherapy, surgery and radiotherapy. The other three patients had 
surgery and radiotherapy only. However, one patient could not be followed up during 
radiotherapy as they were transferred to another hospital. All patients commenced active 
medical treatment one to two weeks after diagnosis. The length of inpatient hospital stay 
was shorter for group two than group one patients (2-3 weeks vs 3-8 weeks) 
5.2. Symptoms affecting food intake 
Prior to commencement of active medical intervention, the synq)toms e>qperienced by 
group one (upper GI tumours) included odynophagia, dysphagia, sore mouth, throat and 
chewing difl&culties. Three of the five brain tumour patients (group two) experienced a 
decrease in appetite, one of whom also had some nausea and vomiting prior to starting 
treatment. There were no other synq)toms reported by group two at this stage. Table 
5.1 summarises the data for all patients together. 
During the treatment phase of medical intervention the variety of syn]5)toms increased to 
include taste changes (33 per cent), poor appetite and for some nausea (Refer to Table 
5.1.). Poor appetite was the most commonly experienced symptom (71 per cent of 
patients). Only one brain tumour patient was included in this figure. 
After discharge some patients reported that syniq)toms subsided but they still existed 
(Refer to Table 5.1). The severity of synoptoms were not recorded. 
TABLE 5.1: Symptoms experienced by aU patients. 
Symptom At initial Ax+ (%)* During Rx"*" 1 week after 
(%)* discharge^ (%) ^ 
Poor appetite 10 (48) 15(71) 13 (68) 
Dysphagia 7(33) 12 (57) 9(47) 
Odynophagia^ 10 (48) 11(52) 9(47) 
Chevdng Difficulty 8(38) 10 (48) 11 (58) 
Dry mouth 6(29) 12 (57) 11(58) 
Sore mouth 2(9) 8(38) 5(10) 
Sore throat 5(24) 8(38) 6(32) 
Taste changes 2(9) 7(33) 7(37) 
Nausea 3(14) 2(9) 0 
Vomiting 1(5) 0 0 
Constipation 3(14) 1(5) 0 
Diarrhoea 1(5) 0 
Other (tired) 1(5) 0 
+ No of patients 
* Total number of patient sample = 21 
# Total number of patient sample =19 
5.3. Dietary Evaluation 
5.3.1 Energy Intake 
a) Group one: Head and neck cancer patients with tumours affecting the GIT. 
Figure 5.1. illustrates the mean estimated energy intake of group one patients over the 
three stages of the study (i.e. prior to commencing medical treatment and receiving 
nutrition intervention; during the course of treatment and one week after discharge from 
medical treatment). In addition, the lowest and highest estimated energy intakes are 
displayed. Comparison of mean dietary intake pre - treatment and during treatment 
indicated a significant increase in energy intake, using a paired t-test (t=2.91 p<0.01). 
The mean energy intake increased 369.31 kcal during treatment (i.e.after nutrition 
intervention) but decreased 119 kcal one week after discharge. This decrease was not 
statistically significant. Furthermore, the mean energy intake one week post discharge, 
was still higher than pre - treatment intake. 


















— statistically significant difference (p < 0.01) 
II not statistically significant 
During treatment the mean energy intake was not statistically different from mean 
estimated requirements (-85.1kcal ± 79.93 [mean ± standard error]). Prior to nutrition 
intervention six patients (38 per cent) were meeting their estimated energy requirements. 
After receiving nutrition counselling and/or intervention thirteen patients (81 per cent) 
met their energy requirements during medical treatment. The number of patients 
decreased to ten (63 per cent) when dietary intake was assessed one week after 
discharge from treatment. 
Oral vs Enterallv fed group one patients 
The percentage of patients meeting energy requirements receiving enteral or oral 
nutrition is con^ared to all group one patients in Figure 5.2. 
Figure 5.2 : Percentage of patients meeting energy requirements receiving enteral 
(n=9) or oral nutrition (n=7) compared to all group one patients (n=16). 













• Enteral • Oral All patients 
Prior to Rx During Rx After d/c 
Corc^arison of dietary intake in enterally fed patients prior to treatment and during 
treatment (i.e.before and after nutrition intervention) indicated a significant increase in 
mean energy intake using the paired t test (t=3.98 p<0.005)). All enterally fed patients 
(n=9) met their estimated energy requirements during treatment. Six of the seven 
patients who continued on enteral feeds after discharge maintained an adequate energy 
intake. During treatment and after discharge, the energy intakes of patients having an 
oral diet were lower than those on enteral feed (see Figure 5.2). 
In contrast to the enterally fed patients the mean energy intake of patients on an oral diet 
did not change significantly during treatment or one week after discharge (using the 
paired t test). 
Five of the patients on an oral diet (71 per cent) were drinking a high protein, high 
energy supplement at least twice a day. Of those patients who consumed an oral diet, 
with or without supplements (n=7) during treatment, only three had estimated energy 
intakes sufficient for their needs. Three of these patients continued an adequate intake 
one week after discharge. 
Despite failing to meet estimated energy requirements, a ftirther three patients increased 
their energy intake during treatment (i.e. after receiving nutrition counselling) by 
approximately 112, 406 and 222kcal (mean = 246 ± 148.5). However, one patient 
decreased their intake during treatment to below estimated requirements. 
Overall, fifteen patients (94 per cent) with tumours affecting the upper gastrointestinal 
tract, met their estimated energy requirements and/or improved their energy intake 
during treatment (i.e. after receiving nutrition intervention). 
b) Group two: patients with brain tumours. 
All patients in group two (n=5) consumed an oral diet, with only one patient having 
commercial supplements. Prior to treatment and nutrition counselling three patients 
received adequate energy fiom their diet, which they maintained during treatment. The 
other two patients increased their food intake approximately 600 and 800 kcal after 
receiving nutrition intervention (during treatment). However, only one of these patients 
met their estimated requirements. One week after discharge, fom^ of the five brain 
tmnour patients met their estimated energy requirements 
A comparison between mean energy intakes of brain tumour patients (group two) with 
group one patients is made in Table 5.2. The mean energy intake of group two patients 
was higher than the mean intake of group one patients having an oral diet only 
throughout the study. Corq)ared to those on enteral feeds their mean energy intake was 
lower both during (2504 vs 2028 kcal) and after discharge fi-om treatment (2450 vs 2078 
kcal). When con^ared to the whole sample, group two had a slightly lower mean energy 
intake during treatment (2194 vs 2028 kcal). However mean energy intake was similar 
after discharge (2080 and 2084 kcal). Due to the small sarq)le size of group two these 
dififerences were not statistically significant. 
TABLE 5.2: The mean ± standard deviation (standard error) for energy intake 
(kcal). 
Type of patient Estimated Intake prior to Intake during Intake one 
requirements interventions intervention week after d/c 
All group one 2331.5 ± 1857.6 ± 2246.8 ± 2057.9 ± 
[Gl} (n=16) 307.2 (76.8) 530.8(132.7)* 507.6 (129.9)* 474.33 (126.8) 
Gl: enterally fed 2465 ± 199.6 1876.2 ± 2504 ±200.8 2450 ± 169.3 
(n=9) (66.53) 495.5 (165.2)^ (69.9)^ (56.4) 
Gl: oral diet 2160 ±348.8 1834 ±613 1918 ±603.5 1707 ± 324 
(n=7) (131.8) (231.7) (228.1) (122.5) 
All group two: 2158 ±357.9 2409 ±1366 2028 ±295.5 2084 ±453.5 
oral diet (n=5) (160) (611) (132.15) (202.8) 
All patients (n=21) 2290.9 ± 1988.9 ± 2194.9 ± 2080.3 ± 
319.5(69.7) 801.7 (174.9) 468.8 (102.3) 457.5 (99.8) 
*p< 0.01 and ^ p < 0.005 
5.3.2. Protein Intake 
Group one: Head and neck cancer patients with tumours affecting the upper GIT. 
The mean and ranges for estimated energy intake of group one patients over the three 
stages of the study (i.e. prior to commencing medical treatment and receiving nutrition 
intervention, during the course of treatment and one w êek after discharge from medical 
treatment) are presented in Figure 5.3. The mean protein intake increased 19.6 g (± 7.5) 
from the pre-treatment to the during treatment dietary assessment. This difference was 
found to be significant using the paired t test (t =2.602, p<0.025). Protein intake was 
significantly higher during treatment than mean estimated requirements (t=2.63 p<0.01). 
One week after discharge, mean protein intake decreased 4.92g (±5.3). However this 
change was not statistically significant. 





















— statistically significant difference (p < 0.01) 
H not statistically significant 
Oral vs Enterallv fed group one patients 
The mean daily protein intake for patients having an oral diet in group one increased 
significantly from the pre treatment to the during treatment dietary assessment (i.e.+ 
25.25g ± 11.7; t= 2.16, p <0.025). Whereas, the mean protein intake for the patients on 
enteral feed did not increase significantly in this time frame. However, all patients (n=9) 
having enteral feeds met their estimated protein requirements during treatment compared 
to five (n=7) of the patients having the oral diet. 
Prior to treatment three of the patients having an oral diet during treatment, met their 
estimated protein requirements compared to four enterally fed patients. Altogether, six of 
the patients having an oral diet increased their protein intake (5-69g; mean = 33.78 ± 
23.1) during treatment. However, only five of these patients maintained their estimated 
protein requirements compared to eight patients who were on enteral feeds one week 
after discharge. Overall, as shown in Table 5.3 the mean protein intake for group one 
patients having an oral diet were very skmlar to those on enteral feed. 
In summary, fourteen (n=16) group one patients met their protein intake during 
treatment and thirteen patients maintained this one week after discharge from treatment. 
Group two: Patients with brain tumours. 
A comparison between mean protein intakes of brain tumour patients (group two) and 
group one patients is made in Table 5.3. The mean protein intake was higher in group 
two patients prior to commencing treatment, but lower during treatment and one week 
after discharge. 
Two of the five brain tumour patients met their estimated protein intakes prior to seeing 
the Chnical Nutritionist. Four of these patients met their requirements during treatment, 
but only two maintained these intakes one week after discharge. 
TABLE 5.3: The mean ± standard deviation (standard error) for protein (g) 
intake 
Type of patient Estimated Intake prior to Intake during Intake one 
requirements interventions intervention week after d/c 
All group one [Gl) 90.38 ±9.16 80.33 ±31.32 99.93 ± 22.24 94.91 ± 12.72 
(n=16) (2.29)^ (7.83)* (5.56)^' (3.40) 
Gl: enterally fed 91.4 ±7.5 83.5 ±31.9 98.7 ±7.8 94.3 ±7.2 
(n=9) (2.5) (10.6) (2.6) (2.4) 
Gl: oral diet 89.1 ±11.5 76.3 ±32.7 101.6 ±33.9 95.5 ±17.3 
(n=7) (4.3) (12.3)̂ ^ (12.8)'' (6.5) 
All group 2: oral 89.9 ± 12.9 116.6 ±86.5 84.7 ±29.6 89.9 ±26.2 
diet (n=5) (5.7) (38.7) (13.2) (11.7) 
All patients (n=21) 90.3 ±9.8 88.9 ±49.8 98.0 ±23.6 93.6 ±16.6 
(2.1) (10.9) (5.1) (3.6) 
* p <0.025 
^p<0.01 
5.3.3. Recommended Dietary Intakes (RDIs) 
Before commencing treatment 24 per cent of patients (n=5) met all the RDIs. Three of 
these patients also had nutrient intakes > to the RDI during treatment and one week after 
discharge. In corqparison, eleven patients (58 per cent) met or exceeded the RDI for 
essential nutrients during the latter two phases of the study only (i.e. after nutrition 
intervention). During the treatment phase alone, fifteen patients met the RDI for all 
essential nutrients (71 per cent). 
All patients recehdng enteral feeding during treatment (n=9) met the RDIs for essential 
nutrients. After nutrition intervention was provided, the number of patients with intakes 
less than the RDI decreased (for the nutrients shown in Table 5.4), in patients having 
enteral feeds and an oral diet. 
TABLE 5.4: Comparison of nutrient intakes with Australian RDIs* 
Number of Patients with Nutrient intakes < 100% RDI 
Nutrient B@ 
Zinc 8 3 6 
Calcium 9 3 1 
Retinol Eq. 7 2 2 
Magnesium 12 5 5 
Vitamin C 4 1 0 
Riboflavin 3 1 1 
Iron 1 1 2 
Niacin 1 1 0 
Thiamin 2 0 0 
NB. RDIs for all other nutrients (except protein) were met. 
• RDIs for use in Australia (National Health and Medical Research Council, 1991). 
A* Dietary intake prior to initial nutritional assessment; total number of subjects = 21. 
B@ Dietary intake during course of medical treatment; total number of subjects = 21. 
C^ Dietary intake one week after discharge from medical treatment: total number of = 19. 
5.4 Anthropometric Measurements 
5.4.1 Weight and Body Mass Index 
Thirteen patients (62% n=21) reported weight loss prior to commencing medical 
treatment and receiving nutrition intervention. Group two patients did not report any 
weight loss. The exact weight loss was not recorded because most respondents were 
uncertain about how much weight they lost. 
For the purpose of this study a gain in weight will be defined as greater than one 
kilogram increase in body weight between initial measurements and the last week of 
treatment. Weight maintenance will be defined as ± 1kg, and weight loss as more than 
1kg decrease in body weight. Figure 5.4. illustrates the weight changes for all patients. 
Eleven patients maintained their body weight throughout the treatment phase (± 1kg). 
Four patients gained weight (2 to 3kg) and six patients lost weight during treatment (1.5 
to 4 kg). The mean weight loss was 2.1kg. 
Figure 5.4: Weight changes for all patients (n=21) from initial assessment to the 
last week of treatment. 
A ten per cent loss of body weight is considered significant and indicative of the need for 
nutrition intervention (Goodwin and Byers, 1993). A ten per cent weight loss is unlikely 
to occur during short treatment periods similar to that of the patients in this study. 
Given that the changes hi weight were small for most patients in this study, an acceptable 
standard of less than five per cent loss of body weight was set. Two patients lost greater 
than five per cent body weight during treatment. 
The mean BMI for group one patients (20.3) was lower than the mean for group two 
(26.6) when nutritional status was assessed initially (Refer to Table 5.5). There were 
small changes ia the BMIs during the course of treatment, however they were not 
statistically significant. At both the initial and last week of treatment assessment, eight 
group one patients (50 per cent) and one group two patient were classed as underweight. 
Three group two patients were actually overweight, one of whom was obese. 
TABLE 5.5: The mean (+SD) and the number of patients with normal values^ for 
BMI, MAMC and TSF on initial assessment (I Ax) and discharge (D/C Ax). 
Indices l A x D/CAx No. pts > normal 
values at I Ax 
No. pts > normal 
values at D/C Ax 
BMI 20.3 ±3.5 20.4 ±3.12 8 (50%) 8 (50%) 
(group 1) (15 - 25)^ (15.3-25) 
BMI 26.2 ±7.3 26.1 ±7.5 4 (80%) 4 (80%) 
(group 2) (16.6 - 36.7) (16.2-36.7) 
MAMC cm 24.84 ±3.06 24.50 ±2.83 10 (62.5%) 9 (56.3%) 
(group 1) (19.87 - 30.07) (19.9-28.3) 
MAMC cm 27.23 ±4.05 26.69 ±4.33 5 (100%) 5 (100%) 
(group 2) (21.25 - 30.28) (20.2 - 29.2) 
TSF mm 7.41 ±4.03 7.54 ±4.01 6 (37.5%) 6 (37.5%) 
(group 1) (4 - 15.5) (3.7-6.5) 
TSF mm 12.75 ±6.55 13.25 ±6.02 4(80) 4(80) 
(group 2) (7-21) (8-21) 
* length of patient stay = one to six weeks 
# Refer to Table 3. l(methods). 
"" Range 
5.4.2 Mid arm muscle circumference and triceps skinfold measurements 
The mean MAMC and TSF were lower for group one patients before and after treatment 
and nutrition intervention (see Table 5.5). Upon entering the study ten (63 per cent) 
group one patients had MAMCs above the 10th percentile and were classed as normal. 
This number decreased to nine patients (56 per cent) at discharge. All MAMCs for the 
brain tumour patients were rated as normal for the duration of the study. 
Six group one patients (37.5 per cent) and four group two patients (80 per cent) had 
TSF measurements above the 10th percentile and were classed as normal for all 
nutritional assessments. As illustrated in Figure 5.5 the TSFs of group one and group 
two patients changed httle from the initial to the final nutritional assessment. 
Figure 5.5 Triceps skinfold measurements for Group one and Group two at the 
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5.5 Biochemistry 
Biochemistry results were available for inpatients only. Therefore the saniqple size for 
group one was reduced to nine and group two remained the same (n = 5) for the 
biochemical indicators. All inpatients underwent some form of surgery that removed a 
tumour and consequently increased their protein and energy requirements. Nine 
inpatients received enteral feeding post surgery for a minimum of 10 days. Those 
patients with percutaneous gastrostomies (PEGs) continued enteral feeding for three to 
eight weeks. The remaining five patients were provided with a high energy menu during 
hospital stay to select their meals fi-om. 
5.5.1 Albumin 
Figure 5.6 illustrates an insignificant increase in mean serum albumin (29.67 ± 3.61 to 
33.3g/L ± 2.96) for patients with tumours affecting the upper gastrointestinal tract after 
they received nutrition intervention (i.e. from initial assessment to the last week of 
admission). As shown m Figure 5.6 the lowest value increased from 23 to 29 g/L and 
the highest value increased from 36 to 38g/L. The serum albumin levels increased for 
seven of the nine group one inpatients during hospital admission (by 1 to 9g/L; mean = 
5.4g/L ±3.6). The albumin levels of the other two patients decreased 2 to 3g/L. During 
the last week of admission, three group one patients had albvimin levels in the borderline 
range. No patients were in the normal range despite some improvements in serum 
albumin levels. 
Group two patients with brain tumours had higher mean serum albumin levels than group 
one patients at all times. The mean serum albumin level for group two increased from 
36g/L (± 2.35) to 38g/L (±2.35) during the last week of admission. Three of the five 
patients in group two maintained their serum albumin levels. The other two patients 
increased their serum albumin levels by 5g/L during treatment. During the last week of 
admission, one patient had albumin levels in the nonnal range, three patients had 7 J f — — • • ' — — 
borderline values and one was classed as abnormal. 
Figure 5.6: Group one: mean albumin and lowest and highest values upon initial 
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5.5.2 Haemoglobin 
The serum haemoglobin level for all group one patients at their initial nutritional 
assessment and at discharge are presented in Figure 5.7. This graph shows that the 
changes and actual levels of haemoglobin varied between patients. The haemoglobin 
values for three patients (n=9) increased during hospital admission (by 6 - 26g/L, mean 
=18.7 + 11). They remaiaed stable for two patients but decreased for three others (by 8 
to 15g/L, mean = 12.6 ± 6.7). The mean haemoglobin values for group one patients 
remained similar, that is 120.22g/L (± 17.01) to 120.44 (± 8.77) upon discharge from 
hospital. Only two patients were in the recommended range when assessed initially by 
the Clinical Nutritionist. This was reduced to one patient during the last week of 
admission. 
Of the five brain tumour patients, three had haemoglobin values below the recommended 
range prior to receiving nutrition intervention. Two patients had below normal values 
during the last week of admission. The mean initial haemoglobin level was 127 g/L (± 
17.9; range = 106 -149). The mean haemoglobin level during the last week of admission 
was 130 (± 17.18; range = 100 - 149). Two patients increased their serum haemoglobin 
values by 7g/L during admission. One patient increased by 2g/L. Another patient 
maintained their haemoglobin levels and one decreased by 2g/L. 
Figure 5.7. Changes in serum Tib levels from initial nutritional assessment until the 
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5.5.3 Total Lymphocyte Count (TLC) 
Figure 5.8 illustrates the decrease in mean TLC (1.26 lO^/L ± 0.44 to 1.09 lO^/L ± 
0.53) for patients with tumours affecting the upper gastrointestinal tract from initial 
nutrition assessment to discharge. As shown in Figure 5.8. the lowest value decreased 
from 0.6 to 0.4 10^/L and the highest value remained the same at 1.9 10^/L. 
Four patients had initial TLCs m the reference range. At discharge, only two patients 
had TLCs in the reference range. The TLC increased by 0.1 - 0.5 lO^/L for three 
patients, however it decreased by 0.1 - 0.9 lO^/L for four patients. Two patients had 
TLCs that remained stable. 
The TLC values for group two patients appeared sUghtly higher. The mean TLC was 
initiaUy 1.46 lO^/L (± 0.96) and 1.8 lO^/L (± 1.8) at discharge. Three of these brain 
tumour patients had TLCs within the reference range upon entering the study, with four 
patients having normal TLCs at discharge. The TLC increased ia three patients and 
decreased in one over the study period. The TLC remained the same for the other brain 
tumour patient throughout hospital admission. 
Figure 5.8: Mean TLC and the lowest and highest values upon initial assessment 
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5.6 Overall Assessment of indicators on nutritional status. 
Table 5.6 compares the number of patients classified as abnormal or borderline for each 
clinical indicator at initial nutritional assessment (Ax) and during the last week of 
treatment. 
TABLE 5.6: Number of patients classified as abnormal or borderline for each 
clinical indicator at initial nutritional Ax and upon discharge 
Indices: Initial Discharge 
Body Mass Index 9 (43%) 9 (43%) 
ic Triceps Skinfold 11 (52%) 11 (52%) 
Mid Arm Muscle Circumference* 6 (29%) 7 (33%) 
Albumin 14(100%) 13 (93%) 
Haemoglobin*** 9 (64%) 11 (79%) 
Total Lymphocyte Count*** 7 (50%) 8 (57%) 
total number of patients = 21 
total number of patients =14 
Note: only one patient in group two (brain tumour) had a BMI and TSF below normal. 
Overall, twelve patients had two or more abnormal or borderhne values and seven 
patients had three or more. The dietary intake (protein and energy) of nine from the 
above twelve patients was inadequate prior to commencing treatment. Six patients 
increased and three patients maintained their nutrient intake after receiving nutrition 
intervention, thus meeting their estimated energy and protein requirements. Therefore, 
nine of the above twelve patients met their dietary requirements during treatment, but 
still had two or more abnormal or borderline values for the indicators measured. 
CHAPTER 6: DISCUSSION 
6.1. Clinical symptoms 
The severity of side effects were not examined in this study, nor has there been much 
research elsewhere to quantify the degree of radiation or surgery side effects in head and 
neck cancer patients. Most studies sino l̂y outline the main side effects of treatment. 
Changes in taste are frequently reported by patients with cancer of the head and neck 
undergoing radiotherapy, ultimately leading to decreased food intake. During treatment, 
33 per cent of patients reported taste changes. This finding differed to that of other 
studies where on one extreme 64 per cent of patients reported taste changes (Donaldson, 
1977) compared to 15 per cent of patients in another study (Carey, 1992). The impact 
of treatment on taste changes in the present study may have been greater in a larger 
patient population. The above research unlike this study, did not iaclude patients 
undergoing surgery. Therefore, due to the variation in treatment methods (including 
different doses of radiation) and differences in patient characteristics, a vahd conq)arison 
between these studies cannot be made. However, it has been well documated in the 
Uterature that taste changes frequently occur. 
The most common symptoms reported during treatment in the present study were 
dysphagia (57 per cent), odynophagia (52 per cent) and dry mouth (57 per cent). These 
symptoms especially compromised the nutrient intake of patients who did not continue or 
cormnence enteral feeding during treatment. The exact impact of side effects and 
symptoms on nutrient intake were not measured directly in this study, but their role in 
reducing the food intake of some patients was apparent. 
6.2. Dietary intake 
Mean energy and protein intake significantly increased (369kcal and 25g/protein) during 
treatment (i.e. post nutritional intervention by the Clinical Nutritionist). Mean protein 
intake was significantly higher than requirements during treatment and mean energy 
requirements were met. On average, most patients maintained adequate nutrient intake 
one week after discharge. Similarly, the study by Ovesen et al, (1993) which exanmed 
the effect of long term nutrition counselhng on the dietary intake of cancer patients 
(using a three day food diary) found an increase in both energy (239kcal) and protein 
intake (lOg/day), in corr^arison to their control group who showed no change in intake. 
In summary, it appears that energy and protein intake signiQcantly increased during 
treatment in the present study as a result of nutrition intervention. However, since a 
control group was not used definite conclusions regarding the effect of nutrition 
intervention cannot be made. 
The findings of the present study contrast to the reports of other authors who did not 
specifically focus on the effect of nutrition intervention. Both Carey, (1992) and 
Chambers, (1993) found that energy intake decreased progressively over a course of 
radiotherapy. However, Carey (1992) did note that protein intake increased sMghtly 
during treatment and this was most likely due to Dietetic education. 
The dietary intake methodology used in these studies differed to the present study (i.e. 
24 hour recall vs diet history) therefore conclusions based on such comparisons are not 
vahd. The diet history reflects usual intake, whereas the 24 hour dietary recall only 
depicts nutrient intake for one day. However, both methods are limited by patients' 
abihty to estimate portion sizes and accurately recall food eaten. 
During treatment the number of patients meeting the RDIs for all nutrients increased 
from 24 per cent (prior to nutrition intervention) to 71 percent. However, only 58 per 
cent of patients appeared to meet all the RDIs at one week after discharge. It is 
acknowledged that the RDIs are based on a large healthy population, hence the rehabihty 
of such analysis is questionable. However, at present these are the only readily available 
estimates of nutrient requirements. It is assumed that cancer patients can have increased 
requirements for some nutrients. Hence, a much smaller number of patients may have 
actually met their body's requirements. Therefore the results must be interpreted with 
caution. 
Improvements in nutrient intake were not supported by significant changes in the clinical 
indicators of nutritional status. However, they may have contributed to the maintenance 
of initial nutritional status throughout the course of active treatment, where increased 
demands were placed upon the patients nutrient stores. Alternately, it may be that the 
dietary data collected gave a false impression of actual nutrient intake. Inaccuracies in 
data collection may be due to the following: 
• During hospital admission the enteral feeding regime in the medical notes were used to 
determine energy and protein intakes for some patients. However, in practice this does 
not always translate into what the patient receives due to possible errors or alternative 
judgements made by other staff involved in the administration of enteral feeds. 
• The diet history used to collect the dietary data was highly subjective. The vaHdity of 
this method depended on the patient's abihty to give correct information on fi-equency 
and an ability to estimate portion sizes correctly (Bingham, et al, 1988; Lee and Nieman, 
1993). The food fi-equency cross check used in this study increased the vahdity of 
information provided. However, since absolute nutrient intake cannot be known for 
certain, the dietary results should be treated with caution. 
6.3. Anthropometric indicators 
Group one patients would be classed as being normal weight and of good nutritional 
status if the mean BMI of the group was the only clinical indicator used in assessment. 
However, analysis of patients on an individual basis portrays a different situation. Several 
patients were underweight and a few were overweight at both commencement and 
conq)letion of treatment. Furthermore, since BMI does not reflect protein stores it can 
give false irr^ression of nutritional status, consequently it cannot be considered in 
isolation. 
The mean BMIs of 20.3kg/m^ at commencement of the study and 20.4kg/m^ upon 
discharge for group one patients was lower than that found by Carey (1992). Carey's 
(1992) study of patients with tumours in the head, neck and pelvic region of the 
gastrointestinal tract reported mean BMIs of 23kg/m2 and 24kg/m^ during week one and 
week six of radiotherapy. Considering that reported heights were used in the BMI 
calculations for this study, the accuracy of the above discrepancy is questionable. 
However, the main objective of this study was to describe changes in nutritional status. 
Therefore, absolute BMIs were less important than actual fluctuations in weight. 
The mean BMI of group two patients was 26kg/m2 on commencement of therapy and 
remained stable throughout the study. Only one patient was classed as underweight. A 
BMI greater than 25 usually indicates a state of over nutrition. However, since protein 
stores usually become depleted in oncology patients, the BMI does not adequately reflect 
the nutritional status of this group. Therefore, other chnical indicators were considered. 
Mid arm muscle circimiference (MAMC) is a usefiil estimate of protein stores in most 
cases. However, in patients with large amounts of body fat (similar to two of these brain 
tumour patients) it is (and was) very difi&cult to get an accurate TSF measurement 
utilising standard skinfold callipers. This leads to the potential miscalculation of 
MAMC. 
Weight changes were not statistically significant, however some trends were evident. All 
patients whose body weight decreased (n=6), were having an oral diet and reported that 
side effects were affecting their food intake. Those patients that gained weight (n=4) or 
maintained their body weight (n=ll) either reported less side effects or were receiving 
enteral feeds. 
In this study, 30 per cent of patients lost weight with the average weight loss being 
2.1kg. Similarly, Carey (1992) and Chambers (1993) reported average weight losses of 
2.3kg and 2.0kg respectively. In comparison, Donaldson, (1977) who studied a variety 
of cancer patients undergoing radiotherapy reported an average weight loss of 3.7 kg 
(for 93 per cent of the study group) over a period of six to eight weeks. It should be 
noted that no specific dietary treatment was given in Donaldson's study (1977) and that 
routine dietary counseling was available to all patients in both Carey's (1992) and 
Chamber's (1993) studies. Most studies of nutritional status in oncology patients have 
focussed on outpatient radiotherapy, and not included surgical patients like the present 
study. Therefore, due to the differences in study designs assumptions based on such 
comparisons are limited. However, there appears to be a general trend to less weight 
loss with the provision of dietary counselling. 
There were insignificant changes in both mean MAMC and TSF measurements despite 
the significant increase hi reported protein and energy intake during treatment. The 
number of patients with normal TSF measurements stayed the same throughout the 
study. However, the number of patients whose MAMC's were classified as normal was 
reduced by one. Overall, 11 patients (52 per cent) had TSF measurements and seven 
patients (33 per cent) had MAMC's that were classified as abnormal, or borderline 
abnormal at completion of the study. 
Although the changes in MAMC were minimal, the MAMC decreased in three patients 
(by 2cm, 1.5 cm and 1 cm). However as suggested earher to confirm a true change in 
MAMC, the change needs to be at least 2.68cm due to potential measurement errors 
(Hall, et al, 1980). The results of the present study were comparable to that of Ovesen 
(1993) and Carey (1992) who also failed to show significant changes in lean body mass 
using the chnical indicator of MAMC. 
Age and sex specific tables were used to calculate percentiles and hence categorise these 
patients. Though, there were still limitations to using such data tables. The primary 
hmitation being that these tables were developed for and based on a healthy population. 
Acceptable and achievable values for anthropometric indicators for specific use in 
oncology patients have not been developed on the professional level. Therefore it may 
be unreaUstic to set outcome goals for improvements in anthropometric indicators in 
cancer patients based on available standards. 
It was not possible to speculate on the origin (Le.protein mass or fat mass) of weight loss 
or gain in the study population given that changes m anthropometric indicators were 
insignificant. Carey's (1992), study showed that mean subscapular skinfold thickness 
decreased over six weeks, whereas triceps skinfold thickness remained stable. Similarly, 
the present study showed insignificant changes in mean triceps skinfold thickness. Other 
skinfold sites were not assessed in this study, therefore hmiting the conclusions that can 
be made. The small changes in TSF that did occur in some patients were potentially due 
to errors in measurement. Over longer periods of time, significant changes in TSF are 
more likely to occur. Ovesen et al (1993) for example, found that triceps skinfold 
measurements increased significantly in oncology patients afl;er five months of nutrition 
counselling. 
In summary, the three anthropometric indicators assessed in this study appear to meet 
some of the requirements of chnical indicators stipulated by the ACHS (ACHS Care 
Evaluation Program, 1991). That is, data were available for these clinical indicators, but 
their ability to reflect gains in fat and protein stores that are known to result from 
improved dietary intake in the normal population is questionable given the average 
patients length of patient stay. The ability of adequate nutrient intake to produce 
improvements in body fat and muscle mass, especially in patients with cancer is still 
debated in the literature. Furthermore, this study questions the usefiihiess of these 
chnical indicators in evaluating the effectiveness of nutrition intervention since it failed to 
show significant improvements in these indicators despite reported improvements in 
dietary intake. 
Overall, it appears that significant improvements in chnical indicators of weight, BMI, 
TSF and MAMC may not have been achievable in the study group for several reasons 
including the following: 
• the duration of medical treatment or hospital admission may have been too short to 
show improvements in these indicators afi;er nutrition intervention had been provided. 
• due to the nature of the disease and its unpredictable effects on the nutritional status of 
these patients in:q)rovements in body con^osition may not be feasible. 
Therefore objectively assessing the goals of nutrition intervention using the chosen 
clinical indicators alone (without quahty of life measures) may not provide meaningfiil 
data on the true effectiveness of nutrition services. If maintenance of body weight and 
composition (irrespective of initial nutritional status) were defined as successfiil 
outcomes it might be concluded that nutrition intervention was effective. That is, fiirther 
weight loss was prevented. Therefore the adequacy of these indicators may depend on 
the goals of nutritional care. 
6.4 Biochemical Indicators 
Biochemistry tests were not routinely performed on outpatients. Therefore these results 
were missing for seven patients in the study (33 per cent). All inpatients were surgical 
patients and consequently had iacreased proteui and energy requirements. Furthermore, 
the physiological stress of surgery and possible infections acquired in hospital were hkely 
to have had an ini^act on the biochemical indicators discussed below. 
All patients had serum albumin levels below normal at commencement of treatment and 
only one patient was within the normal range during the last week of hospital stay. Mean 
albumin levels did not significantly increase during treatment. However, the trend was 
for albumin levels to increase or remain the same for most patients. 
There are numerous factors that limit the use of albumin as a chnical indicator, which 
have been further substantiated by this study. Albumin's long half hfe of 18-21 days 
means positive changes reflecting improved food intake (as in this study) were unlikely 
to occur in short stay patients (who are increasingly con^rising a greater percentage of 
the hospital population). Furthermore, the view that the metabohc response to stress is a 
more important contributittg factor to hypoalbunmaemia than inadequate nutrient intake 
in the hospitaHsed patient (Klein, 1990) may partially explain the findings of this study. 
Many researchers beheve that hypoalbuminaemia in patients with cancer is maioly a 
consequence of the disease. In addition, lower albumin levels have been reported to 
occur with aging. Therefore for some of the older patients in our sample, achieving 
normal albumin levels may not be the goal. The exact goals of treatment were not 
defined in this study. For cancer patients, it may be reasonable that lower levels of 
albumin are the accepted norm How albumin levels should be interpreted in these 
patients needs to be defined, or alternate indicators used. 
Normal serum albumin values have been found in undernourished cancer patients 
(Brookes, 1985) therefore it may also be a false indicator of good nutritional status. 
Perhaps a more sensitive indicator such as C-reactive protein may be a more meaningful 
indicator. However, this test was not readily available or commonly used at St Vincent's 
Hospital during the study period. 
There was an insigniJ&cant increase in mean serum haemoglobin from admission to 
discharge, however the number of patients with abnormal values increased from 9 to 11 
(79 per cent) over the period of the study. The mean haemoglobin was lower than 
accepted values and lower than the mean found in another study of head and neck cancer 
patients (Basset and Dobie, 1983). Basset and Dobie's (1983) study suggested that 
haemoglobin was not a very sensitive indicator of protein calorie depletion. Serum 
haemoglobin may have been shown to be a useftd indicator of baseline nutritional status 
in some studies, but its long half life of 120 days mean that it is of hmited value when 
monitoring the effect of nutrition intervention in short stay hospital patients. The mean 
length of hospital stay during the study was 3 weeks (range = 2-8 weeks), too short for 
significant changes in haemoglobin to occur due to alterations in nutrient intake. 
Furthermore, the fluctuations evidenced in this study (a decrease in haemoglobin for 
most) were most likely due to the blood loss from surgery rather than from decreased 
nutrient intake during hospital. 
Similarly, the decrease in mean TLC found in this study may have been caused from the 
stress response to surgery or mild infections acquired in hospital rather than impaired 
nutrient intake per se. Furthermore, the small sample size meant that the actual changes 
in TLC were not statistically significant. 
Overall, the findings of this study were supported by other authors who question the 
usefiihiess of the above biochemical indicators in similar groups. The clinical indicators 
of albumin, haemoglobin and total lymphocyte count were severely limited by several 
variables other than nutrient intake. They were hmited by their half hves, the effect of 
cancer itself treatment (e.g. surgery) and the aging process. The influence of such 
factors on the above biochemical indicators of nutritional status, make their usefiikess 
either alone or in combination with each other highly questionable. In terms of meeting 
the requirements of clinical indicators as defined by the ACHS, they were neither readily 
available (for outpatients), or meaningful (relevant) for evaluating the effect of nutrition 
intervention ui the head and neck cancer patients studied. 
6.5 Quality of life 
The goal of nutritional care in the cancer patient is always to support nutritional status, 
body composition and quahty of life (Ottery, 1995). The effect of improved food intake 
on quahty of life, a major objective of overall cancer care was not measured in this study. 
According to Ottery (1995) quahty of life issues are gaining acceptance as legitimate 
areas for study and outcome analysis m the field of oncology. Therefore, using a 
subjective survey instrument such as that used by Hauchecome et al (1994) may be more 
appropriate to use in patients when inq)rovements in objective criteria are not likely to 
occur, as in the clinical care of oncology patients. 
CHAPTER 7: CONCLUSION 
The nutritional status of cancer patients is affected by several factors other than dietary 
intake. This study assessed the nutritional status of head and neck cancer patients 
undergoing active medical treatment and nutrition intervention at St Vincent's Hospital, 
Sydney. Several anthropometric, biochemical and dietary indicators of nutritional status 
were trialed in the study group to determine their usefiilness in evaluating the outcome of 
nutrition intervention. 
As hypothesised, estimated nutrient intake in^roved or remained adequate after most 
patients received nutrition intervention, both during treatment and at one week after 
discharge. Mean protein and energy intake significantly increased fi-om pre - treatment 
dietary assessment to the during treatment assessment for patients with tumours affecting 
the upper gastrointestinal tract (p<0.025 and p< 0.01). Dietary intake decreased 
insignificantly after discharge from treatment. 
The changes in nutrient intake for the patients with brain tumours were not statistically 
significant. This was likely to be due to the small group size and because three patients 
were aheady meeting their estimated energy and protein requirements prior to 
commencing treatment. After discharge fi-om treatment four of these five patients were 
meeting their estimated requirements. 
Despite most patients increasing nutrient intake, estimated requirements were not met 
by some patients having an oral diet. Whereas, aU patients having enteral feed met their 
estimated energy and protein requirements. The limitations of using the dietary history 
method to estimate nutrient intake must be considered when interpreting the findings. 
Improvements in nutrient intake did not contribute to significant changes in either 
anthropometric or biochemical indicators of nutritional status as hypothesised. 
However, some trends in weight changes emerged. Most patients maintained weight and 
three patients gained weight. Five patients lost between two and four kilograms over the 
course of treatment. The triceps skinfold thickness and mid arm muscle circumference 
measurements failed to reflect these changes. The hmitation of using one body site as a 
clinical indicator of body con^)osition was noted previously. Weight however, offered 
the most value in terms of changes in anthropometric measurements in this study group. 
The changes in the biochemical indicators albumin, haemoglobia and total lymphocyte 
count were not statistically significant. Haemoglobin and the total lymphocyte count 
appeared to decrease over the study period, however this was most hkely due to blood 
loss, stress and mild infections acquired in hospital rather than nutrient intake per se. 
Furthermore, all patients continued to have below normal albumin levels throughout the 
study and as stated previously the effect of the cancer itself on the host was likely to be 
partially responsible for this finding. 
Using the ACHS guidelines to evaluate the adequacy of these clinical indicators it 
appears that the availabihty of anthropometric indicators were good, whereas the 
biochemical indicators were less accessible, being available only for iapatients. Achieving 
improvements in these indicators over short periods of time (e.g. three to six weeks) 
were unlikely, due to several factors that can influence changes in these biochemical or 
anthropometric indicators. These include: errors in measurement; the long half life of 
albumin and haemoglobin and the sensitivity of all three biochemical indicators to the 
physiological stress of chronic illness and/or radical treatment. 
This study has provided httle evidence that supports the use of the above indicators as 
measures of nutritional care outcomes in clinical practice. Particularly, the use of 
albumin, haemoglobin and total lyn:q)hocyte count (either alone or in combination with 
each other) to monitor the effectiveness of nutrition intervention appears highly 
questionable. 
CHAPTER 8: LIMITATIONS OF THE STUDY 
An extensive discussion of the limitations of the study were presented in Chapter 6. A 
brief summary of the main issues is provided below. 
1. There was no control group as it was unethical to deny usual care to patients. 
Therefore we were unable to measure the true intact of nutrition counseling and 
support on nutritional status. However we can infer some conclusions from the results. 
2. The small san^le size was too small for significant changes to be detected between 
many of the parameters measured. Therefore it was not possible for meaningM 
conclusions to be drawn from the results, especially for the biochemical indicators. 
3. Biochemistry tests were not performed on outpatients, therefore fiuther reducing the 
size of the study group for these indices. 
4. There were a limited number of readily available indicators of nutritional status that 
could be used for objective assessment of the outcomes of nutritional care from the 
outset. Other biochemical indicators such as C-reactive protein are known to be more 
sensitive indicators however this test was not commonly performed at the hospital. 
5. Considering the long half lives of albumin and haemoglobin and the lack of post 
discharge follow up, the length of medical treatment may have been insufficient for 
significant changes in indicators to occur. 
6. Single site skinfold measurements were used. Therefore possible changes in body 
composition in other areas could not be determined. 
7. There may have been some degree of error involved in collecting the anthropometric 
measurements. Inter-observer variabihty was ehminated using the same observer for all 
measurements. How^ever it was hkely that some error occurred in performing repeat 
measures. 
8. The standards used to con^are normal values for anthropometry and Recommended 
Daily Intakes (RDIs) are based on data from healthy individuals, hence their 
appropriateness for the study group is questionable. 
9. The values for apparent protein and energy intake should be treated cautiously due to 
inaccuracies in the dietary data collection method. The diet history is prone to both 
interviewer bias and respondent errors in estmiation amounts. Common descriptions of 
portion sizes were " a small bowl/piece" etc which may have lead to either under or over 
estimation of nutrient intake. 
10. The measures of quahty of life were excluded as indicators of the efiectiveness of 
nutrition intervention, due to limitations to the size of the study given the short time 
frame available for data collection. Supporting quahty of life is a major objective of the 
nutritional care of the oncology patient and should be measured to enable the 
effectiveness of nutrition intervention to be evaluated using a holistic approach. 
CHAPTER 9: RECOMMENDATIONS 
The results of this study suggest that the use of albumm, haemoglobin and total 
lymphocyte count either siagly or as combined measures of nutritional status is highly 
questionable. Future studies should examine the usefiikess and feasibility of using other 
biochemical indicators such as C-reactrve protein which has been reported to have 
greater sensitivity to changes in nutrient icitake. 
Where anthropometry may be used a means of monitoring the effect of nutrition 
intervention, multiple skinfold sites should be measured. All anthropometry 
measurements should be continued post discharge from medical treatment, as this is 
usually too short a time frame for significant changes to occur. 
Future research is needed to define meaningftil chnical indicators that can be used to 
evaluate the effectiveness of nutritional care in oncology patients. In developing such 
chnical indicators measures of quahty of life should be included as this is an important 
part of the overall care of the patient with cancer. Furthermore, measures of quahty of 
life are particularly usefiil when improvements m objective criteria are unlikely to occur, 
as is frequently the case with oncology patients. 
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ST. VINCENT'S HOSPITAL / UNIVERSITY OF WOLLONGONG CONSENT 
FORM FOR RESEARCH STUDIES 
Project Title: "Evaluating the effectiveness of nutrition intervention: A pilot study 
head and neck cancer patients at St Vincent's Hospital" 
Investigators: 
Di Cheah BSc Hons (Nutrition and Biology), Dietitian St Vincent's Hospital 
Louise Houtzager BSc Candidate for MSc (Nutrition and Dietetics) 
Contact person: 
Di Cheah Ph: 339 1111 Pager 6235 
1. You are invited to participate in the experiment described below. 
2. Background to experiment 
This research is being conducted as part of a Master of Science degree supervised by 
Boris Gazibarich in the Department of PubHc Health and Nutrition at the University of 
WoUongong and Di Cheah, the Deputy in Charge of Nutrition Services at St Vincent's 
Hospital. 
The Nutrition Services Department at St Vincent's Hospital are evaluating the effect of 
nutrition intervention on patients with cancer in the head and neck region. The results 
miay assist the Department in improving their service. 
3. Description of Experiment - methods and demands 
Nutritional Status will be assessed weekly during medical treatment by: 
1. taking a skinfold measurement on the back of your upper arm - this involves gently 
pinching the skin and taking a measurement using a device called a skinfold caHper. 
2. measuring the circumference of your upper arm using a tape measure. 
3. recording your weight using standard scales. 
(The above procedures will take approximately ten minutes). 
4. evaluating the results jfrom your biochemical tests that will be obtained from your 
medical record 
Background information will also be obtained from your medical record. This will 
include: your age, diagnosis, date of diagnosis, site of cancer, type of treatment and 
phase of treatment. 
Food intake will be monitored in the following manner: 
In addition to the chnical nutritionist's routine assessment of your previous diet and 
symptoms and usual follow up during treatment, an additional assessment will be made 
one week after discharge from treatment by telephone. This telephone interview will take 
approximately 20 minutes and will be made at a time convenient to you. 
4. I acknowledge that I have read the above statement which explains the nature and 
object and the possible risks of the investigation, and the statement has been explained to 
me to my satisfaction. Before signing this document I have been given the opportunity 
to ask questions relating to any possible physical and mental harm I might suffer as a 
result of my participation and I have received satisfactory answers. I have also been 
informed that I may not receive any benefits from participating in this study. 
5. My decision whether or not to participate will not prejudice my fiiture relations with 
St. Vincent's Hospital and the University of Wollongong. If I decide to participate, I am 
free to withdraw my consent and to discontinue participation at any time without 
prejudice. 
6. I agree that research data gathered from the results of the study may be published 
provided my name is not used. 
DATE Signature of Patient or Authorised 
Representative 
7. I have fiilly explained to the patient the nature and purpose of the 
programme and the procedures to be employed as described above and such risks as are 
involved in their performance. 
DATE Signature of Responsible 
Investigator 
8. The foregoing is an accurate summary of the explanation which was made to the 
patient/volunteer, and the undersigned witnessed the signatures. 
d a t e Signature of Auditor-Witness 
Note: If you have any enquires regarding the conduct of the research please contact the 
secretary of the University of Wollongong Human Ethics Committee on: (042) 21 3079. 
APPENDIX C 
Dietary Data Collection Sheet 































Do you modify the texture of your 
food in any way? 
Other: 
APPENDIX D 
Anthropometry, biochemistry, symptom 





Adm Date: Referral Date: 
Referral Source: 
Has pt seen a dietitian before? Yes/No 
Biochemistry/Anthropometry 
Reported Height (cm): 
Weight History: 
Dx: 
Date of Dx: 
Chemo Rx Y/N 
Radio Rx Y/N 
Surgery Y/N 































A P P E N D I X E 






body mass index (BMI) 
triceps skinfold thickness (TSF) 
mid arm muscle circumference (MAMC) 
BIOCHEMICAL INDICATORS: 
serum albumin (alb) 
haemoglobin (hb) 
total lymphocyte count (TLC) 
Dietary intake: Energy intake (kcal) 
Pt Requirements Pre - Treatment During Treatment One Week Post 
during Rx D/C 
a 1860 1451 1673 1181 
b 2774 3000 2997 2145 
c* 2400 2553 2537 na 
d* 2900 2207 2923 2304 
e 2021 1195 1975 1635 
f 1928 1183 1794 1912 
h 2156 1832 1287 1547 
i* 2400 1945 2416 2416 
j 1800 2751 1760 1756 
k 2350 1344 1750 1589 
1 2363 2415 2486 2440 
m 1810 1849 2128 1845 
n 2678 4501 2129 2681 
0 1869 1200 1312 1447 
P 2300 2160 2269 1927 
q* 2300 1356 2338 na 
r* 2500 1714 2545 2545 
s* 2600 2443 2585 2700 
t* 2500 999 2564 2564 
u* 2210 1815 2200 2200 
Y* 2375 1854 2425 2425 
* Enterally fed by either NG or PEG during treatment and after discharge (except c, d and q) 
Protein intake (g) 
Pt Requirements 
during Rx 
Pre - Treatment During 
Treatment 
One Week Post 
D/C 
e 79 70.4 74 72.9 
f 100 74.6 119 85 
j 76.5 82 52 68 
1 88 84.9 93.9 90 
n 106 271 121 134 
c 95 111 100 na 
d 97 104.9 115 82 
i 90 109 93 93 
q 75 51 92 na 
r 96 57.3 101 101 
s 101 133 102 99 
t 91.5 49 101 101 
u 87 82 88 88 
V 90 54 96 96 
a 84 51.5 71.8 101 
b 103.5 98.6 103.6 102 
h 84 93.7 67.7 89.2 
k 88.5 54.4 123.8 79.3 
m 82.5 88.4 138 117.3 
0 75 27.2 64 69 





on Ax* two three four five six seven eight 
s 20.1 20.1 19.4 19.6 20.1 20.1 
V 17.6 17.6 18 
u 15 15.3 15.3 
q 16.6 16.7 16.1 17 
c 19 18 18 
p 27 26.6 26.2 26.2 25.9 
h 22.2 22.2 21.9 21.5 21.5 20.7 
a 25 25 26 25 25 25 25 
b 17.3 17.3 17.7 17.9 18.06 18.4 18.3 18.2 
m 21.7 21.7 21.7 21.9 22.5 
i 24 24.2 23.2 22.7 24 24 
0 17.15 17.5 18.7 18.7 19 18.7 
k 18 18.25 18.4 
d 24 24 23 23 23 23.4 
t 18.8 18.2 18.9 18.8 18.5 
r 21.97 21.6 22.3 21.6 21.6 21 21.7 22.3 
Group 2 patients 
j 36.7 36.7 36.7 
e 27 28 28 28 
f 16.6 16.2 16.2 
1 27 27 27 27.7 27.3 27.3 26.3 
n 23.6 23.3 23.3 23.1 23.2 






two three four five six seven eight 
a 28.2 28.2 28.2 28.6 28.2 28.3 28.3 
b 23.4 23.4 23.4 23.9 23.36 23.35 23.38 23.38 
c 24.3 24.3 24.3 
d 28.56 28.56 28.12 28.5 28.5 
h 27.3 27.3 27.3 27.3 27.3 25.35 25.37 
i 26.46 27.47 26.47 26.24 26.2 26.1 26.1 
k 22.37 22.37 22.34 
m 28 28 28 28 27.98 
0 22.37 22.39 22.34 22.34 22.34 22.34 
P 30.07 29.06 29.03 28.62 28.6 
q 20.28 20.28 20.28 20.25 
r 25.2 25.7 25.2 24.2 23.7 23.4 24.24 
s 24.8 24.8 24.3 24.3 24.35 24.35 
t 24.35 24.35 24.35 24.35 24.35 24.35 
u 19.87 19.87 19.87 
V 21.87 21.87 21.8 
e 28.8 28.8 28.8 28.8 
f 21.25 20.2 20.2 
n 30.28 30.24 29.24 29.24 29.24 29.24 
1 28.5 28.5 28.5 28.5 28.5 28.5 28.5 




on Ax* two three four five six seven eight 
a 9 10 9.5 12 11 11 11 
b 4 4 3.5 3.7 4.5 4.5 4 3.7 
0 4 4 5 5 5 5 
P 13.5 13 13 13 12 12 
k 4 4 5 
m 15.5 15.5 15.5 15.5 16.5 
h 5 5 5 5 5 4.5 4 
c 5 5 5 
d 14 13.5 13.5 13.5 14 
q 7 7 7 8 
r 8.5 9 9 9 8 8 8 8 
u 4 4 4 
V 4 4 5 
i 11 10 9 8 9 10 10 
s 5 5 5 5 4.5 4.5 
t 5 5 5 5 5 5 
e 21 21 21 21 
f 8 9 9 
n 7 8 8 8 8 8 
1 15 15 15 15 15 15 15 
* Initial Assessment by the Clinical Nutritionist 
Weight on Ax* two three 
Weeks 
four five six seven eight 
(kg) 
a 87 88 89 88 88 88 88 
b 60 60 61.5 62 62.5 64 63.5 
c 63 60 60 
d 68 65 65 65 66 
i 68 68.5 65.6 64 64.5 65 65 
q 40.8 41.3 39.7 42 
0 45 46 49 49 50 48 
p 77 76 76 75 75 74 
r 65 64 66 64 64.25 62.35 64.3 
s 65 63 63.5 64 65 65 
t 59 61.35 61 60 60 60 
u 50.5 51.5 51.5 
k 53.5 54 54.5 
m 55 55 55 55.5 57 
h 57 57 56 55 55 55 53 
V 51 51 52 
e 72 73 73 74.5 
f 41 40 40 
n 88 87 87 87 86 86.5 
j 94 94 
1 80 80 80 82 81 80 79.5 
* Initial Assessment by the Clinical Nutritionist 
Biochemical Indicators 
Albumin ( /̂L^ Weeks 
Group 1 On Adm^ On Ax* two three four five six 
c 32 32 29 
d 36 30 36 36 37 
q 37 36 32 34 na na 
r 26 30 32 32 na 35 
V 23 29 32 
i 30 29 35 41 38 
s 30 31 
t 38 30 32 na 
u 30 30 32 
Group 2 
e 38 38 38 
f 33 33 33 
n 37 37 37 
1 38 43 
j 34 39 
Ub g/L 
Group 1 
c 142 140 119 
d 126 109 104 111 111 109 
q 138 141 100 95 131 na 
r 96 103 97 104 106 119 
u 123 134 118 
i 100 99 118 138 125 
t 142 130 116 115 
V 112 112 112 
s 130 136 
Group 2 On Adm On Ax. two three four five six 
e 149 148 149 
f 128 135 135 
n 119 106 113 
1 140 142 
i 113 111 
Total Lymphocyte Count xlO^/L 
Group 1 
c 0.6 0.8 1.1 
d LI 1.9 1.1 1.3 1.3 1.9 
q 1.5 1.5 0.9 0.6 0.4 
r 1.1 0.9 0.8 0.5 0.7 1 
u 1.6 0.8 1 
i 1 0.9 1 2.1 1.2 
s 1.1 1.1 
t 0.6 0.8 0.2 0.3 
V 1.7 1.8 1.8 
Group 2 
e 1.6 2.3 2.2 
f 0.3 0.5 0.3 
n 0.9 1 1.9 
1 2.9 2.4 
j 1.5 2.2 
# Adm: admission biochemistry for those whose nutritional assessment was not performed in the 
first week of hospital admission. 
* On Ax: the first nutritional assessment conducting after referral to the clinical nutritionist. 
APPENDIX F 
Patient background data: age, sex, admission type (inpatient or outpatient), site of 
primary tumour, stage and treatment procedures 






a 66 M OP Right tonsil T3N1 SURGERY: tracheostomy & 
excision of right tonsillar 
tumour 
RADIOTHERAPY: 30 days 
60 M OP Right T2N0 SURGERY: 
supraglottis laryngopharynectomy & 
jejunal free flap repair. 
RADIOTHERAPY: 35 days 
c 60 M IP Soft palate T3N0 RADIOTHERAPY: 35 days 
d 60 M IP Mouth T3N0 SURGERY: Tracheostomy 
right hemi-mandibulectomy 
excision of tumour and 
pectorahs major flap repair 
i 62 M I P & O P Right tonsillar T3N1 
fossa 
SURGERY: mandibulectomy 
& jejunal free flap repair 
RADIOTHERAPY: 
discontinued at week 4 (20 
days) 
76 IP Hypopharynx T3N1 SURGERY: total 
laryngectomy & jejunal free 
flap repair 
o 84 OP Throat T3N0 RADIOTHERAPY: 30 days 
49 M OP Soft palate & 
oral/pharynx 
T3N1 SURGERY: Pharyngeal 
laryttgectomy, modified neck 
dissection, laparotomy & 
jejunal free flap repair 
RADIOTHERAPY: 30 days 
h 52 M OP Hypopharynx T3N1 RADIOTHERAPY: 30 days 
r 68 M IP Piriform fossa T3N0 SURGERY: pharyngo-laryn -
gectomy & free flap repair 
s 61 M I P & O P Tongue T3N1 SURGERY: excision of 
tiimour on base of tongue 
RADIOTHERAPY: 20 days 
t 62 M IP&OP Tongue T2N0 SURGERY: neck dissection 
& removal of tongue tumour. 
RADIOTHERAPY: 30 days 
m 77 F OP Hard palate T3N1 RADIOTHK-RAPY: 21 days 
r 75 M OP Left side of 
neck 
T3N0 SURGERY: excision of 
tmnour 1 month ago 
u 63 M IP Supraglottis T3N1 RADIOTHERAPY: 30 days. 
Patient seen on week 4 
V 67 M IP Oral cavity T3N0 SURGERY: tracheostomy 
modify radical neck 
dissection, mandibulectomy 




RADIOTHERAPY: 30 days 
at another institution 
f 75 F IP Brain N/A SURGERY: excision of 
tumour 
RADIOTHERAPY: 12 days 
n 34 M IP Brain N/A SURGERY: excision of 
tumour 
RADIOTHERAPY: 30 days 
j 32 F IP Brain N/A SURGERY: excision of 
tumour. 
RADIOTHERAPY: 30 days 
1 48 M IP & OP Brain N/A SURGERY: excision of 
tumour 
RADIOTHERAPY: 25 days 
CHEMOTHERAPY: 4* 
(1/12) 
N/A data not available 
